<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Biochem J</journal-id><journal-id journal-id-type="iso-abbrev">Biochem J</journal-id><journal-id journal-id-type="pmc-domain-id">671</journal-id><journal-id journal-id-type="pmc-domain">portlandopen</journal-id><journal-id journal-id-type="publisher-id">BCJ</journal-id><journal-title-group><journal-title>Biochemical Journal</journal-title></journal-title-group><issn pub-type="ppub">0264-6021</issn><issn pub-type="epub">1470-8728</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Portland Press Open Access</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12203974</article-id><article-id pub-id-type="pmcid-ver">PMC12203974.1</article-id><article-id pub-id-type="pmcaid">12203974</article-id><article-id pub-id-type="pmcaiid">12203974</article-id><article-id pub-id-type="pmid">40302223</article-id><article-id pub-id-type="doi">10.1042/BCJ20253061</article-id><article-id pub-id-type="publisher-id">BCJ-2025-3061</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology &amp; Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Parasitology</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology</subject></subj-group></article-categories><title-group><article-title>Cytokines from parasites: manipulating host responses by molecular mimicry</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3216-1944</contrib-id><name name-style="western"><surname>Maizels</surname><given-names initials="RM">Rick M.</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="cor1" ref-type="corresp"/><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; Original Draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; Original Draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; Review &amp; Editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; Review &amp; Editing</role><email>rick.maizels@glasgow.ac.uk</email></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1300-7407</contrib-id><name name-style="western"><surname>McSorley</surname><given-names initials="HJ">Henry J.</given-names></name><xref rid="aff2" ref-type="aff">2</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; Original Draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; Original Draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; Review &amp; Editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; Review &amp; Editing</role><email>HMcsorley001@dundee.ac.uk</email></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9279-2890</contrib-id><name name-style="western"><surname>Smits</surname><given-names initials="HH">Hermelijn H.</given-names></name><xref rid="aff3" ref-type="aff">3</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; Original Draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; Original Draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; Review &amp; Editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; Review &amp; Editing</role><email>h.h.smits@lumc.nl</email></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7234-342X</contrib-id><name name-style="western"><surname>ten Dijke</surname><given-names initials="P">Peter</given-names></name><xref rid="aff4" ref-type="aff">4</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; Original Draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; Original Draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; Review &amp; Editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; Review &amp; Editing</role><email>P.ten_Dijke@lumc.nl</email></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3320-8054</contrib-id><name name-style="western"><surname>Hinck</surname><given-names initials="AP">Andrew P.</given-names></name><xref rid="aff5" ref-type="aff">5</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; Original Draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; Original Draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; Review &amp; Editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; Review &amp; Editing</role><email>ahinck@pitt.edu</email></contrib></contrib-group><aff id="aff1"><label>1</label>School of Infection and Immunity, University of Glasgow, Glasgow, U.K</aff><aff id="aff2"><label>2</label>Division of Cell Signalling and Immunology, School of Life Sciences, University of Dundee, Dundee, U.K</aff><aff id="aff3"><label>3</label>Department of Immunology, Leiden University Medical Center, Leiden, Netherlands</aff><aff id="aff4"><label>4</label>Oncode Institute and Department of Cell and Chemical Biology, University of Leiden, Leiden, Netherlands</aff><aff id="aff5"><label>5</label>Department of Structural Biology, University of Pittsburgh School of Medicine, Pittsburgh PA 15260, U.S.A.</aff><author-notes><corresp id="cor1"><bold>Correspondence:</bold> Rick M. Maizels (<email>rick.maizels@glasgow.ac.uk</email>)</corresp></author-notes><pub-date pub-type="collection"><month>5</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>29</day><month>4</month><year>2025</year></pub-date><volume>482</volume><issue>9</issue><issue-id pub-id-type="pmc-issue-id">491657</issue-id><fpage>433</fpage><lpage>449</lpage><history><date date-type="received"><day>31</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>01</day><month>4</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>29</day><month>04</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>28</day><month>06</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-06-28 12:25:16.873"><day>28</day><month>06</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 The Author(s).</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License 4.0 (CC BY)</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="BCJ-482-09-BCJ20253061.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="pdf" xlink:href="BCJ-482-09-BCJ20253061.pdf"/><abstract><p>Helminth parasites have evolved sophisticated methods for manipulating the host immune response to ensure long-term survival in their chosen niche, for example, by secreting products that interfere with the host cytokine network. Studies on the secretions of <italic toggle="yes">Heligmosomoides polygyrus</italic> have identified a family of transforming growth factor-&#946; (TGF-&#946;) mimics (TGMs), which bear no primary amino acid sequence similarity to mammalian TGF-&#946;, but functionally replicate or antagonise TGF-&#946; effects in restricted cell types. The prototypic member, TGM1, induces <italic toggle="yes">in vitro</italic> differentiation of Foxp3<sup>+</sup> T regulatory cells and attenuates airway allergic and intestinal inflammation in animal models. TGM1 is one of a family of ten TGM proteins expressed by <italic toggle="yes">H. polygyrus</italic>. It is a five-domain modular protein in which domains 1&#8211;2 bind TGFBR1, and domain 3 binds TGFBR2; domains 4&#8211;5 increase its potency by binding a co-receptor, CD44, highly expressed on immune cells. Domains 4&#8211;5 are more diverse in other TGMs, which bind co-receptors on cells such as fibroblasts. One variant, TGM6, lacks domains 1&#8211;2 and hence cannot transduce a signal but binds TGFBR2 through domain 3 and a co-receptor expressed on fibroblasts through domains 4&#8211;5 and blocks TGF-&#946; signalling in fibroblasts and epithelial cells; T cells do not express the co-receptor and are not inhibited by TGM6. Hence, different family members have evolved to act as agonists or antagonists on various cell types. TGMs, which function by molecularly mimicking binding of the host cytokine to the host TGF-&#946; receptors, are examples of highly evolved immunomodulators from parasites, including those that block interleukin (IL)-13 and IL-33 signalling, modulate macrophage and dendritic cell responses and modify host cell metabolism. The emerging panoply and potency of helminth evasion molecules illustrates the range of strategies in play to maintain long-term infections in the mammalian host.</p></abstract><kwd-group><kwd>CD44</kwd><kwd>cytokines</kwd><kwd>evolution</kwd><kwd>immunomodulation</kwd><kwd>mimicry</kwd></kwd-group><funding-group><award-group><funding-source>LONGFONDS|Accelerate</funding-source><principal-award-recipient>McSorley Henry J., Maizels Rick M., McSorley Henry J.</principal-award-recipient></award-group><award-group><funding-source>UK Medical Research Council</funding-source><award-id>MR/S000593/1</award-id><principal-award-recipient>McSorley Henry J.</principal-award-recipient></award-group><award-group><funding-source>National Institutes of Health (NIH)</funding-source><award-id>RO1 GM58670</award-id><principal-award-recipient>Hinck Andrew P.</principal-award-recipient></award-group><award-group><funding-source>National Institutes of Health (NIH)</funding-source><award-id>RO3 AI53915</award-id><principal-award-recipient>Hinck Andrew P.</principal-award-recipient></award-group><award-group><funding-source>Wellcome Trust</funding-source><award-id>Ref 219530</award-id><principal-award-recipient>Maizels Rick M.</principal-award-recipient></award-group><award-group><funding-source>Wellcome Trust</funding-source><award-id>Ref 221914</award-id><principal-award-recipient>McSorley Henry J.</principal-award-recipient></award-group><award-group><funding-source>Wellcome Trust</funding-source><award-id>Ref 306173</award-id></award-group></funding-group><counts><page-count count="17"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1"><title>Parasite immune evasion</title><p>Pathogens that establish chronic infections in their host must first evade the immune responses designed to lyse, kill, incapacitate, or eject them. Micro-organisms can take the approach of outpacing immunity and undergo rapid selection of escape mutants, while protozoal parasites can vary their surface-exposed antigens, such as with trypanosomes [<xref rid="BCJ-2025-3061C1" ref-type="bibr">1</xref>,<xref rid="BCJ-2025-3061C2" ref-type="bibr">2</xref>], rendering the antibody response raised against them to be non-functional. This strategy is not available to slower growing helminth macro-parasites, which do not proliferate in their hosts and, therefore, cannot rapidly select for advantageous mutations. Hence, many parasites take alternative routes through transition into different life stages and/or by releasing immunomodulatory factors, which tailor the immune response to their benefit [<xref rid="BCJ-2025-3061C3" ref-type="bibr">3</xref>]. Such sophisticated immunomodulation can result in a tolerance to the parasite, which at best can benefit both the parasite and host by minimising collateral damage, immune hyper-responsiveness and enabling asymptomatic chronic infection. More detrimentally, helminth infection can result in immune suppression, co- or hyper-infection, cancer progression/metastasis and reduced vaccination protection against other pathogens [<xref rid="BCJ-2025-3061C4" ref-type="bibr">4&#8211;6</xref>].</p><p>In viral infections, immune evasion factors are well understood and shown to suppress critical pathways, such as major histocompatibility complex class I antigen presentation at virtually every step in the process. In contrast, helminth immunomodulation has only begun to be understood with the recent expansion of molecular studies on these parasites. A broad range of mediators have now been discovered [<xref rid="BCJ-2025-3061C7" ref-type="bibr">7&#8211;11</xref>], which either block anti-helminth immune responses or induce immune tolerance depending on their life stage or tissue residence.</p></sec><sec id="s2"><title>Transforming growth factor-&#946; &#8211; a pivotal cytokine</title><p>Cytokines are soluble messenger proteins for intercellular communication that activate and regulate various aspects of immunity, inflammation and tissue homeostasis [<xref rid="BCJ-2025-3061C12" ref-type="bibr">12&#8211;15</xref>]. The complexity of the cytokine network reflects the diverse nature of pathogens, each requiring a tailored immune response. Interestingly, redundancy within this network may have arisen from pathogens attempting to disrupt cytokine functions. This review focuses not on the role of cytokines during an infection but rather on how parasites alter the host cytokine network to their benefit.</p><p>A particularly intriguing study area is the hijacking of transforming growth factor-&#946; (TGF-&#946;) signalling by secreted parasite cytokines, exploiting host cell surface TGF-&#946; serine/threonine kinase receptors (TGFBR1 and TGFBR2). TGF-&#946; is an exceptional cytokine with functions far beyond the immune system, playing crucial roles in development, cellular metabolism, tissue homeostasis and repair [<xref rid="BCJ-2025-3061C16" ref-type="bibr">16</xref>,<xref rid="BCJ-2025-3061C17" ref-type="bibr">17</xref>]. Within the immune system, TGF-&#946; is largely viewed as an anti-inflammatory cytokine through its induction of regulatory T cells, but in parallel, it acts to drive class switching and differentiation of IgA<sup>+</sup> B cells and modifies dendritic cell (DC) and macrophage phenotypes [<xref rid="BCJ-2025-3061C18" ref-type="bibr">18</xref>]. The critical nature of TGF-&#946;-mediated immune regulation is highlighted by the early mortality of mice lacking TGF-&#946;1, through the development of multi-organ inflammatory disease, particularly in the intestinal tract [<xref rid="BCJ-2025-3061C19" ref-type="bibr">19</xref>]. Due to the critical role of TGF-&#946; signalling in tissue differentiation and formation, mice lacking the other isoforms (TGF-&#946;2 and TGF-&#946;3) show congenital developmental defects [<xref rid="BCJ-2025-3061C20" ref-type="bibr">20</xref>,<xref rid="BCJ-2025-3061C21" ref-type="bibr">21</xref>], and animals deficient in TGF-&#946; receptor II (TGFBR2) suffer embryonic or perinatal mortality [<xref rid="BCJ-2025-3061C19" ref-type="bibr">19</xref>].</p><p>While TGF-&#946; is critical for survival in mammals, it poses threats &#8212; especially in cancer [<xref rid="BCJ-2025-3061C22" ref-type="bibr">22</xref>]. The tumour microenvironment often contains elevated levels of TGF-&#946;, which has been found to block T cell activation during checkpoint immunotherapy [<xref rid="BCJ-2025-3061C23" ref-type="bibr">23</xref>,<xref rid="BCJ-2025-3061C24" ref-type="bibr">24</xref>]. As a potent immune suppressor, TGF-&#946; is also detrimental in various infectious settings [<xref rid="BCJ-2025-3061C25" ref-type="bibr">25</xref>], particularly in parasitic infections. This was first reported in the moderation of T cell responses to the river blindness nematode <italic toggle="yes">Onchocerca volvulus</italic> [<xref rid="BCJ-2025-3061C26" ref-type="bibr">26</xref>], and in the high levels of serum TGF-&#946; in patients with Chagas&#8217; disease, caused by the protozoan <italic toggle="yes">Trypanosoma cruzi</italic>, linked to the development of myocardiopathy [<xref rid="BCJ-2025-3061C27" ref-type="bibr">27</xref>].</p><p>In experimental animal models, an evident role for TGF-&#946; was revealed upon infection by the murine intestinal helminth <italic toggle="yes">Heligmosomoides polygyrus</italic>, in which administration of the small molecule inhibitor SB431542 (that blocks the kinase activity of TGFBR1 and closely related receptors) accelerated worm expulsion [<xref rid="BCJ-2025-3061C28" ref-type="bibr">28</xref>]. Parallel results were obtained using the neutralising anti-TGF-&#946; monoclonal antibody 1D11 in mice, significantly reducing infection with another intestinal parasite <italic toggle="yes">Trichuris muris</italic> [<xref rid="BCJ-2025-3061C29" ref-type="bibr">29</xref>]. <italic toggle="yes">H. polygyrus</italic> infection also elicits <italic toggle="yes">in vivo</italic> expansion of regulatory T cells that are required for parasite persistence [<xref rid="BCJ-2025-3061C30" ref-type="bibr">30</xref>]. The ability of <italic toggle="yes">H. polygyrus</italic> to stimulate Tregs suggested that it may activate host TGF-&#946; signalling, a proposition that was confirmed when secretions collected from the parasite <italic toggle="yes">in vitro</italic> (<italic toggle="yes">H. polygyrus</italic> excretory/secretory products, HES) were added to T cells and induced expression of transcription factor Foxp3. Induction was found to be inhibited by SB431542 [<xref rid="BCJ-2025-3061C28" ref-type="bibr">28</xref>], confirming that the parasite could directly address the TGF-&#946; pathway. Similar TGF-&#946;-like activity has been reported in excretory/secretory (ES) products of a related Trich&#959;strongylid nematode, <italic toggle="yes">Teladorsagia circumcincta</italic> [<xref rid="BCJ-2025-3061C28" ref-type="bibr">28</xref>] and in extracts of a rodent filarial nematode <italic toggle="yes">Litomosoides sigmodontis</italic> [<xref rid="BCJ-2025-3061C31" ref-type="bibr">31</xref>], but only in the case of <italic toggle="yes">H. polygyrus</italic> has the active principle been identified as described below.</p></sec><sec id="s3"><title>Identification of the TGF-&#946; mimics from <italic toggle="yes">H. polygyrus</italic></title><p>Since HES is a complex mixture of many hundred soluble proteins released by <italic toggle="yes">H. polygyrus</italic>, this material was fractionated by ion exchange and size exclusion chromatography, and fractions were screened for TGF-&#946;-like activity. Proteins in active fractions were identified by mass spectrometry reconciled to a transcriptomic database from different stages of the parasite [<xref rid="BCJ-2025-3061C32" ref-type="bibr">32</xref>,<xref rid="BCJ-2025-3061C33" ref-type="bibr">33</xref>]. Selected candidates were expressed in a mammalian cell system as recombinant proteins, one of which proved to be a highly potent activator of TGF-&#946;-like signalling, both in triggering an intracellular effector SMAD3-dependent reporter in fibroblasts, and by the induction of Foxp3 in murine T cells [<xref rid="BCJ-2025-3061C34" ref-type="bibr">34</xref>]. Remarkably, this active protein does not share primary amino acid sequence similarity with any TGF-&#946; family member, which includes three TGF-&#946; isoforms, activins and bone morphogenetic proteins [<xref rid="BCJ-2025-3061C35" ref-type="bibr">35</xref>]. It is, however, distantly related to the Complement Control Protein (CCP) family, which, although barely apparent at the amino acid sequence level (<xref rid="BCJ-2025-3061F1" ref-type="fig">Figure&#160;1a</xref>), is confirmed by conservation of three-dimensional structure (<xref rid="BCJ-2025-3061F1" ref-type="fig">Figure&#160;1b</xref>) [<xref rid="BCJ-2025-3061C36" ref-type="bibr">36</xref>]. Interestingly, the parasite product has acquired several insertions of amino acid tracts that enlarge external loops compared with canonical domains, such as human complement receptor CD46 (<xref rid="BCJ-2025-3061F1" ref-type="fig">Figure&#160;1b</xref>).</p><fig position="float" id="BCJ-2025-3061F1" fig-type="figure" orientation="portrait"><label>Figure 1</label><caption><title>Sequence and structural characteristics of TGM1 and CCP proteins.</title><p>(<bold>a</bold>) Alignment of TGM1 D3 with domain 2 of human CD46 [<xref rid="BCJ-2025-3061C36" ref-type="bibr">36</xref>]. Identical residues are shown in inverse shading, similar residues in shaded boxes. Amino acid positions in the respective proteins are indicated above and below the alignment. (<bold>b</bold>) Structural comparison of TGM1 D3 [<xref rid="BCJ-2025-3061C36" ref-type="bibr">36</xref>], left, with domain 2 of human CD46 (PDB 1CKL), centre and overlay of both structures, right. N- and C-termini of the domains are indicated, and positions of key amino acids. The four &#946; sheets are indicated, as is the &#945;1 helis. HVL, Hyper-Variable Loop. This part of the figure is reproduced from Ref. <xref rid="BCJ-2025-3061C36" ref-type="bibr">36</xref> in the <italic toggle="yes">Journal of Biological Chemistry</italic>, in accordance with the republishing policy of the American Society for Biochemistry and Molecular Biology. (<bold>c</bold>) Alpha fold model of TGM1, indicating receptor specificities of the different domains, and the experimentally determined dissociation constants (<italic toggle="yes">Kd</italic>) for TGFBR1 and TGFBR2. Affinities of TGM4 and TGM6 for these receptors are given in Table 1.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="BCJ-482-09-BCJ20253061-g001.jpg"/></fig><p>Importantly, unlike the mature bioactive TGF-&#946; protein &#8211; which consists only of the ~110 aa C-terminal domain of a longer precursor &#8211; the <italic toggle="yes">H. polygyrus</italic> protein contains five homologous but nonidentical domains each forming a self-contained module, connected by short connecting segments (<xref rid="BCJ-2025-3061F1" ref-type="fig">Figure&#160;1c</xref>). A further striking distinction is that TGF-&#946; is synthesised as an inactive pre-protein and stored until activated by integrins or a proteolytic event and released from latency-associated partners [<xref rid="BCJ-2025-3061C37" ref-type="bibr">37</xref>,<xref rid="BCJ-2025-3061C38" ref-type="bibr">38</xref>]. In contrast, the helminth product is immediately competent as a full-length native protein, and it could be argued that the parasite needs no such restraint on the activity of its immune modulator. Thus, it was named TGM1 indicating that it mimics TGF-&#946; without being an evolutionarily related homologue. As detailed below, the domains act as modular units, each conferring separate functional properties to the full-length protein.</p><p>TGM1 replicates the functional effects of TGF-&#946; across a range of immune settings (<xref rid="BCJ-2025-3061F2" ref-type="fig">Figure&#160;2</xref>). For example, both murine [<xref rid="BCJ-2025-3061C39" ref-type="bibr">39</xref>] and human [<xref rid="BCJ-2025-3061C40" ref-type="bibr">40</xref>] T cells respond to TGM1 by inducing Foxp3 expression specifying Treg function. A closer comparison of the dose responses to the two ligands shows that while TGF-&#946; activates fibroblasts at lower concentrations than TGM1, the latter is more potent than TGF-&#946; at higher levels, displaying a steeper slope indicative of co-operativity in binding [<xref rid="BCJ-2025-3061C39" ref-type="bibr">39</xref>]. Similarly, SMAD2/3 phosphorylation in T cells is more rapid in response to TGF-&#946;, but the slower response to TGM1 is sustained for longer [<xref rid="BCJ-2025-3061C39" ref-type="bibr">39</xref>]. As will be discussed below, the discovery of diverse co-receptor interactions with TGM1, but not TGF-&#946;, may provide a mechanistic explanation for these observations.</p><fig position="float" id="BCJ-2025-3061F2" fig-type="figure" orientation="portrait"><label>Figure 2</label><caption><title>Immunological functions of TGM1 <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic>.</title><p>Schematic representing the various immune functions of TGM1. Clockwise from top left. (<bold>a</bold>) Induction of Foxp3 expression in murine [<xref rid="BCJ-2025-3061C34" ref-type="bibr">34</xref>,<xref rid="BCJ-2025-3061C39" ref-type="bibr">39</xref> ] and human [<xref rid="BCJ-2025-3061C40" ref-type="bibr">40</xref>] T cells, representing the regulatory T cell (Treg) phenotype. (<bold>b</bold>) <italic toggle="yes">In vivo</italic> suppression of experimental autoimmune encephalomyelitis by adoptively transferred Tregs generated by <italic toggle="yes">in vitro</italic> treatment with TGM1, compared with TGF-&#946;-induced Tregs [<xref rid="BCJ-2025-3061C39" ref-type="bibr">39</xref>]. (<bold>c</bold>) Reduction in cardiac injury during myocardial infarction by intravenous (i.v.) administration of TGM1 [<xref rid="BCJ-2025-3061C39" ref-type="bibr">39</xref>]. (<bold>d</bold>) Acceleration of skin wound healing in mice by topical application of TGM1 [<xref rid="BCJ-2025-3061C41" ref-type="bibr">41</xref>]. (<bold>e</bold>) Amelioration of colitis in RAG-deficient mice receiving Foxp3-negative T cells, in animals given subcutaneous osmotic minipumps releasing TGM1 [<xref rid="BCJ-2025-3061C42" ref-type="bibr">42</xref>]. (<bold>f</bold>) Suppression of allergic airway eosinophilic inflammation in bronchoalveolar lavage fluid (BALF) in mice receiving intranasal Alternaria alternata fungal allergen, and treated with intraperitoneal (i.p.) TGM1 [<xref rid="BCJ-2025-3061C43" ref-type="bibr">43</xref>]. (<bold>g</bold>) Inhibition of LPS-driven IL-6 release from murine bone marrow-derived macrophages in the presence of TGM1 [<xref rid="BCJ-2025-3061C44" ref-type="bibr">44</xref>]. TGF, transforming growth factor; TGM, transforming growth factor-&#946; mimics.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="BCJ-482-09-BCJ20253061-g002.jpg"/></fig><p>Although Foxp3<sup>+</sup> Tregs induced by TGF-&#946; signalling are functionally immunosuppressive, they may not maintain this phenotype and can revert to a Foxp3<sup>-</sup> effector phenotype, especially in an inflammatory environment [<xref rid="BCJ-2025-3061C45" ref-type="bibr">45</xref>]. However, a greater proportion of cells activated by TGM1 retain Foxp3 expression after transfer into mice with intestinal inflammation induced by dextran sodium sulphate, than is the case for TGF-&#946;-induced Tregs [<xref rid="BCJ-2025-3061C39" ref-type="bibr">39</xref>]. TGM1 has a greater capacity to convert human Th17 effectors into Foxp3<sup>+</sup> Tregs, arguing that memory as well as na&#239;ve T cells are converted into the regulatory compartment [<xref rid="BCJ-2025-3061C40" ref-type="bibr">40</xref>]. TGM1-induced Tregs are also fully functional with equivalent potency to TGF-&#946;-induced Tregs when transferred to mice in an experimental autoimmune encephalomyelitis model [<xref rid="BCJ-2025-3061C39" ref-type="bibr">39</xref>]. Additionally, soluble TGM1 protein administered intraperitoneally protects mice against both airway allergy [<xref rid="BCJ-2025-3061C43" ref-type="bibr">43</xref>] and inflammatory colitis [<xref rid="BCJ-2025-3061C42" ref-type="bibr">42</xref>], and in the latter model, oral administration of TGM1 also attenuated disease [<xref rid="BCJ-2025-3061C46" ref-type="bibr">46</xref>], although in the <italic toggle="yes">in vivo</italic> setting, TGF-&#946; signalling is likely to activate multiple cell types in addition to Tregs. In other analyses, TGM1 given intravenously reduced heart damage and scarring following myocardial infarction in mice [<xref rid="BCJ-2025-3061C47" ref-type="bibr">47</xref>], while when applied to skin wounds, it accelerated wound repair with a qualitative shift to scar-free healing that even renewed hair follicle formation [<xref rid="BCJ-2025-3061C41" ref-type="bibr">41</xref>].</p><p>Further investigation of the <italic toggle="yes">H. polygyrus</italic> secretome characterised by proteomic analysis of HES products [<xref rid="BCJ-2025-3061C32" ref-type="bibr">32</xref>,<xref rid="BCJ-2025-3061C33" ref-type="bibr">33</xref>] revealed a larger family of ten TGF-&#946; mimic (TGM) proteins [<xref rid="BCJ-2025-3061C48" ref-type="bibr">48</xref>], (<xref rid="BCJ-2025-3061T1" ref-type="table">Table&#160;1</xref>) comprising a variable number of homologous but non-identical domains (<xref rid="BCJ-2025-3061F3" ref-type="fig">Figure&#160;3a</xref>). Like other proteins, each domain contains at least two disulphide bonds that are fully conserved across all domains of each TGM family member; within the <italic toggle="yes">H. polygyrus</italic> genome, domains are each encoded by two exons with boundaries coinciding with domain junctions, indicative of an evolutionary module that can be duplicated and reduplicated over time. Indeed, a phylogenetic tree (<xref rid="BCJ-2025-3061F3" ref-type="fig">Figure&#160;3b</xref>) suggests that the three-domain proteins, TGM6, 9 and 10, are ancestral to the longer homologues, in line with earlier work indicating that domain (D)5 of TGM-10 may be the most primordial domain in the family [<xref rid="BCJ-2025-3061C51" ref-type="bibr">51</xref>]. Of note, TGM1&#8211;6 are predominantly produced by adult worms, and TGM7&#8211;10 by the tissue-dwelling larvae [<xref rid="BCJ-2025-3061C33" ref-type="bibr">33</xref>,<xref rid="BCJ-2025-3061C52" ref-type="bibr">52</xref>].</p><table-wrap position="float" id="BCJ-2025-3061T1" orientation="portrait"><label>Table 1</label><caption><title>Features of TGM family members.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">&#8195;NCBI</th><th align="left" rowspan="1" colspan="1">MFB-F11 SMAD</th><th align="left" rowspan="1" colspan="1">T cell Foxp3</th><th align="left" rowspan="1" colspan="1">&#8195;TGFBR1</th><th align="left" rowspan="1" colspan="1">TGFBR2</th><th align="left" rowspan="1" colspan="1">Co-receptor(s)</th><th align="left" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">TGM1</td><td align="left" rowspan="1" colspan="1">422 aa SP + 5 domains</td><td align="left" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="MG099712">MG099712</ext-link> AT059092</td><td align="left" rowspan="1" colspan="1">+++</td><td align="left" rowspan="1" colspan="1">+++</td><td align="left" rowspan="1" colspan="1">90 &#177; 1 nM</td><td align="left" rowspan="1" colspan="1">610 &#177; 10 nM</td><td align="left" rowspan="1" colspan="1">CD44 30 nM</td><td align="left" rowspan="1" colspan="1">[<xref rid="BCJ-2025-3061C34" ref-type="bibr">34</xref>,<xref rid="BCJ-2025-3061C48" ref-type="bibr">48</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">TGM2</td><td align="left" rowspan="1" colspan="1">430 aa SP + 5 domains</td><td align="left" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="MG429737">MG429737</ext-link> <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="AVN88293">AVN88293</ext-link></td><td align="left" rowspan="1" colspan="1">+++</td><td align="left" rowspan="1" colspan="1">+++</td><td align="left" rowspan="1" colspan="1">(100% identical to TGM-1)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">[<xref rid="BCJ-2025-3061C48" ref-type="bibr">48</xref>] Ntang, E.Y.<xref rid="BCJ-2025-3061T1FN2" ref-type="table-fn"><sup>1</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">TGM3</td><td align="left" rowspan="1" colspan="1">429 aa SP + 5 domains</td><td align="left" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="MG429738">MG429738</ext-link> <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="AVN88294">AVN88294</ext-link></td><td align="left" rowspan="1" colspan="1">+++</td><td align="left" rowspan="1" colspan="1">+++</td><td align="left" rowspan="1" colspan="1">(100% identical to TGM-1)</td><td align="left" rowspan="1" colspan="1">(100% identical to TGM-1)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">[<xref rid="BCJ-2025-3061C48" ref-type="bibr">48</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">TGM4</td><td align="left" rowspan="1" colspan="1">422 aa SP + 5 domains</td><td align="left" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="MG429739">MG429739</ext-link> <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="AVN88295">AVN88295</ext-link></td><td align="left" rowspan="1" colspan="1">&#8211;</td><td align="left" rowspan="1" colspan="1">++</td><td align="left" rowspan="1" colspan="1">5.0 &#177; 0.1 nM</td><td align="left" rowspan="1" colspan="1">116 &#177; 2 &#181;M</td><td align="left" rowspan="1" colspan="1">CD44 20 nM, CD49d CD206</td><td align="left" rowspan="1" colspan="1">[<xref rid="BCJ-2025-3061C48" ref-type="bibr">48</xref>,<xref rid="BCJ-2025-3061C49" ref-type="bibr">49</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">TGM6</td><td align="left" rowspan="1" colspan="1">254 aa SP + 3 domains</td><td align="left" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="MG429741">MG429741</ext-link> <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="AVN88297">AVN88297</ext-link></td><td align="left" rowspan="1" colspan="1">&#8211;</td><td align="left" rowspan="1" colspan="1">&#8211;</td><td align="left" rowspan="1" colspan="1">N/A (D1-2 are absent)</td><td align="left" rowspan="1" colspan="1">220 &#177; 100 nM</td><td align="left" rowspan="1" colspan="1">TBD : Not CD44</td><td align="left" rowspan="1" colspan="1">[<xref rid="BCJ-2025-3061C48" ref-type="bibr">48</xref>,<xref rid="BCJ-2025-3061C50" ref-type="bibr">50</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">TGM7</td><td align="left" rowspan="1" colspan="1">599 aa SP + 7 domains</td><td align="left" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="MG429742">MG429742</ext-link> <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="AVN88298">AVN88298</ext-link></td><td align="left" rowspan="1" colspan="1">&#8211;</td><td align="left" rowspan="1" colspan="1">&#8211;</td><td align="left" rowspan="1" colspan="1">Not tested</td><td align="left" rowspan="1" colspan="1">Not tested</td><td align="left" rowspan="1" colspan="1">TBD : Not CD44</td><td align="left" rowspan="1" colspan="1">[<xref rid="BCJ-2025-3061C48" ref-type="bibr">48</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">TGM9</td><td align="left" rowspan="1" colspan="1">251 aa SP + 3 domains</td><td align="left" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="MG429744">MG429744</ext-link> <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="AVN88300">AVN88300</ext-link></td><td align="left" rowspan="1" colspan="1">&#8211;</td><td align="left" rowspan="1" colspan="1">Not tested</td><td align="left" rowspan="1" colspan="1">N/A (D1-2 are absent)</td><td align="left" rowspan="1" colspan="1">Not tested</td><td align="left" rowspan="1" colspan="1">TBD : Not CD44</td><td align="left" rowspan="1" colspan="1">Mullin, T. and Singh, S.P.<xref rid="BCJ-2025-3061T1FN2" ref-type="table-fn"><sup>1</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">TGM10</td><td align="left" rowspan="1" colspan="1">251 aa SP + 3 domains</td><td align="left" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="MG429745">MG429745</ext-link> <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="AVN88301">AVN88301</ext-link></td><td align="left" rowspan="1" colspan="1">&#8211;</td><td align="left" rowspan="1" colspan="1">Not tested</td><td align="left" rowspan="1" colspan="1">N/A (D1-2 are absent)</td><td align="left" rowspan="1" colspan="1">Not tested</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Ciancia, C.<xref rid="BCJ-2025-3061T1FN2" ref-type="table-fn"><sup>1</sup></xref></td></tr></tbody></table><table-wrap-foot><fn id="BCJ-2025-3061T1FN1"><p>TGM5 and TGM8 are not included as they have not been expressed or tested in experimental settings so far.</p></fn><fn id="BCJ-2025-3061T1FN2"><label>1</label><p>Unpublished studies.</p></fn><fn id="BCJ-2025-3061T1FN3"><p>SP+, predicted signal peptide (aa 1-18). TBD, to be determined.</p></fn></table-wrap-foot></table-wrap><fig position="float" id="BCJ-2025-3061F3" fig-type="figure" orientation="portrait"><label>Figure 3</label><caption><title>TGM family member domain organisation and phylogenetic relationship.</title><p>(<bold>a</bold>) (Top section) Domain organisation of TGM1 and corresponding 11 exons in the <italic toggle="yes">H. polygyrus</italic> genome (Roman numerals); yellow C letters in black circles denote Cys residues. All disulphide bonds are intra-domain. (Main section) Organisation of domains in 10 family members, with percent amino acid identity of each domain to the corresponding domain of TGM1. &#916; denotes absence of the domain(s). Note TGM7 and TGM8 have two additional domains, percentage identities shown are as indicated by colouring, with those with D4 of TGM1. Schematic is updated from Smyth et al [<xref rid="BCJ-2025-3061C48" ref-type="bibr">48</xref>] with corrected percent identities for D4-5 of TGM2 and the domains of TGM10 realigned. (<bold>b</bold>) Phylogenetic tree of the 10 full-length sequences of TGM family members. Numerals represent <italic toggle="yes">P</italic> values for branching topography. NB: For clarity, the TGM proteins are shown hyphenated (TGM-1), although normally the hyphen is omitted. TGF, transforming growth factor; TGM, transforming growth factor-&#946; mimics.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="BCJ-482-09-BCJ20253061-g003.jpg"/></fig></sec><sec id="s4"><title>TGF-&#946; receptor binding domains</title><p>A functional analysis of TGM1 in which amino (N)- and carboxy (C)-terminal domains were deleted showed that the minimal structure required for signalling through the TGF-&#946; pathway comprises D1-3 [<xref rid="BCJ-2025-3061C48" ref-type="bibr">48</xref>]. Biophysical studies by surface plasmon resonance (SPR) and isothermal titration calorimetry established that D1-2 bind TGF-&#946; receptor subunit I (TGFBR1) and D3 binds TGFBR2 [<xref rid="BCJ-2025-3061C36" ref-type="bibr">36</xref>] (<xref rid="BCJ-2025-3061F1" ref-type="fig">Figure&#160;1c</xref>). Mapping of the binding sites on TGFBR1 and TGFBR2 using nuclear magnetic resonance [<xref rid="BCJ-2025-3061C36" ref-type="bibr">36</xref>] further showed that D1-2 and D3 engage similar structural features and residues on these receptors as does the native ligand, TGF-&#946;. Recently, a high-resolution (1.4 &#197;) structure of the D3-TGFBR2 complex (<xref rid="BCJ-2025-3061F4" ref-type="fig">Figure&#160;4a</xref>) revealed the remarkable mimicry of the binding interactions as compared with mammalian TGF-&#946;, in spite of an entirely different structural framework (<xref rid="BCJ-2025-3061F4" ref-type="fig">Figure&#160;4b</xref>).</p><fig position="float" id="BCJ-2025-3061F4" fig-type="figure" orientation="portrait"><label>Figure 4</label><caption><title>Mimicry of TGFBR2 binding by TGM domain 3.</title><p>(<bold>a</bold>) Structure of TGM6-D3 (magenta) bound to the human TGFBR2 ectodomain (blue). Structure was determined using X-ray crystallography and was determined to a resolution of 1.4 &#197; [<xref rid="BCJ-2025-3061C50" ref-type="bibr">50</xref>]. Central hydrophobic interaction in which TGFBR2 Ile<sup>76</sup> inserts into a pocket formed by TGM6-D3 Ile<sup>78</sup>, Tyr<sup>80</sup> and Tyr<sup>93</sup> is highlighted by yellow shading. Peripheral hydrogen-bonded ion pairs, TGFBR2 Asp<sup>55</sup> and Glu<sup>78</sup> with TGM6-D3 Arg<sup>95</sup> and Arg<sup>38</sup>, respectively, and TGFBR2 Asp<sup>141</sup> and Glu<sup>142</sup> with TGM6-D3 Tyr<sup>80</sup> and Arg<sup>82</sup>, respectively, that further stabilise the interaction and add specificity are highlighted by blue shading. (<bold>b</bold>) Structure of TGF-&#946;3 (olive) bound to the human TGFBR2 ectodomain (blue). Structure was determined using X-ray crystallography and was determined to a resolution of 3.0 &#197; [<xref rid="BCJ-2025-3061C53" ref-type="bibr">53</xref>]. Central hydrophobic interaction in which TGFBR2 Ile<sup>76</sup> inserts into a pocket formed by TGF-&#946;3 Trp<sup>332</sup>, Tyr<sup>390</sup> and Val<sup>392</sup> is highlighted in yellow. Peripheral hydrogen-bonded ion pairs, TGFBR2 Asp<sup>55</sup> with TGF-&#946;3 Arg<sup>394</sup> and TGFBR2 Glu<sup>142</sup> with TGF-&#946;3 Arg<sup>325</sup>, that further stabilise the interaction and add specificity are highlighted in yellow. TGF, transforming growth factor; TGM, transforming growth factor-&#946; mimics.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="BCJ-482-09-BCJ20253061-g004.jpg"/></fig><p>While domains D1-3 bind to the canonical receptors that are required for signalling, the function of D4 and D5 has only recently been clarified. Our findings indicated that TGM1 lacking D4 and D5 is considerably less potent than the full-length TGM1, suggesting that D4-5 are necessary for achieving the full potency of TGM1. This led us to speculate that D4 and D5 mediate cell specificity and potency by interacting with co-receptors. Indeed, TGM1 D4 and 5 have been found to interact with cell adhesion receptor CD44, which has a cell-type-restricted expression pattern and is essential for the potency of TGM1 [<xref rid="BCJ-2025-3061C54" ref-type="bibr">54</xref>] (<xref rid="BCJ-2025-3061F1" ref-type="fig">Figure&#160;1c</xref>). CD44 is an adhesion and migration molecule [<xref rid="BCJ-2025-3061C55" ref-type="bibr">55</xref>,<xref rid="BCJ-2025-3061C56" ref-type="bibr">56</xref>] widely expressed on immune cells and up-regulated on key subsets of memory/effector T cells [<xref rid="BCJ-2025-3061C57" ref-type="bibr">57</xref>], but is also found on endothelial and epithelial cells. In the context of immune cells, CD44 is required for efficient TGM1 activation, as shown both by reduced responses of CD44-deficient cells, and the loss of potency when D4-5 are removed from TGM1 and the remaining D1-3 is tested on fibroblasts or T cells [<xref rid="BCJ-2025-3061C54" ref-type="bibr">54</xref>]. Hence, it is suggested that TGM1 may have evolved to target CD44-expressing immune cells to dampen the host immune system during <italic toggle="yes">H. polygyrus</italic> infection; whether it also modulates epithelial cells such as CD44<sup>+</sup> intestinal stem cells [<xref rid="BCJ-2025-3061C58" ref-type="bibr">58</xref>] remains to be determined.</p><p>Mammalian TGF-&#946; homodimers have a compact structure that interacts with ubiquitously expressed TGFBR1 and TGFBR2 to assemble TGFBR1<sub>2</sub>:TGFBR2<sub>2</sub> heterotetramers [<xref rid="BCJ-2025-3061C59" ref-type="bibr">59</xref>]. In contrast, TGM1 engages with TGFBR1, TGFBR2, through two independent modules (D1-2, D3) to form a TGFBR1:TGFBR2 heterodimer, and in association with a co-receptor through a third module (D4-5). For the biological activity induced by TGF-&#946;1 and TGF-&#946;3, the presence of TGFBR1 and TGFBR2 alone is sufficient. However, for TGF-&#946;2, both TGFBR1 and TGFBR2 and the TGFBR3/betaglycan co-receptor are required [<xref rid="BCJ-2025-3061C60" ref-type="bibr">60</xref>,<xref rid="BCJ-2025-3061C61" ref-type="bibr">61</xref>]. TGFBR3 primes cells to respond to TGF-&#946;2 by potentiating receptor complex assembly and signalling and is a key determinant for TGF-&#946;2 cell specificity [<xref rid="BCJ-2025-3061C44" ref-type="bibr">44</xref>,<xref rid="BCJ-2025-3061C62" ref-type="bibr">62</xref>]. The way TGM1 binds to cell surfaces is, therefore somewhat similar to TGF-&#946;2, as signalling requires the cooperation of three receptors. However, unlike TGF-&#946;2 where the co-receptor TGFBR3 is displaced by the signalling receptors [<xref rid="BCJ-2025-3061C44" ref-type="bibr">44</xref>,<xref rid="BCJ-2025-3061C63" ref-type="bibr">63</xref>], TGM1 independently binds TGFBR1 through D1-2, TGFBR2 through D3 and remains bound to the co-receptor through D4-5 as it signals through TGFBR1 and TGFBR2.</p></sec><sec id="s5"><title>TGM co-receptor binding and cell specificity</title><p>Of the family of ten TGMs, TGM1&#8211;4 share a similar modular structure with five discrete domains, while TGM5, TGM6, TGM9 and TGM10 lack one or two domains, and TGM7 and TGM8 have acquired two additional domains (<xref rid="BCJ-2025-3061F3" ref-type="fig">Figure&#160;3a</xref>). The D1-3 of TGM1 that bind to TGFBR1 and TGFBR2 share high amino acid sequence identity (90&#8211;100%) with the corresponding domains of TGM2, 3, 4 and 5 but have lower sequence identity (50&#8211;66%) with those of TGM6&#8211;10. At the biophysical level, D3 of TGM1, 4 and 6 has each been shown to interact with TGFBR2 [<xref rid="BCJ-2025-3061C36" ref-type="bibr">36</xref>,<xref rid="BCJ-2025-3061C49" ref-type="bibr">49</xref>,<xref rid="BCJ-2025-3061C50" ref-type="bibr">50</xref>], and this suggests that all TGMs that include D3 may interact with TGFBR2, and those with D12 with TGFBR1.</p><p>The D4-5 of TGM1 are similar (87&#8211;99%) to D4-5 of TGM2, 3, 4 and 5 and are likely to share the same co-receptors. Indeed, we confirmed experimentally that TGM1 and TGM4 share CD44 as a co-receptor partner [<xref rid="BCJ-2025-3061C49" ref-type="bibr">49</xref>,<xref rid="BCJ-2025-3061C54" ref-type="bibr">54</xref>], but distinct from TGM1, TGM4 also interacts with CD49d (integrin &#945;4) and CD206. Co-receptors confer cell specificity for TGF-&#946; signalling as the individual affinity of TGMs for the TGFBRs can be moderate to low, such that the D3 of TGM1 and TGM4 binds TGFBR2 with affinities in the range of 1&#8211;2 and 50&#8211;100 &#956;M, respectively [<xref rid="BCJ-2025-3061C36" ref-type="bibr">36</xref>,<xref rid="BCJ-2025-3061C49" ref-type="bibr">49</xref>]. The broader range of cell surface co-receptors for TGM4 compared with TGM1 results in increased cell specificity of TGM4 for monocytes rather than T lymphocytes or fibroblasts [<xref rid="BCJ-2025-3061C49" ref-type="bibr">49</xref>], prescribing a myeloid cell preference for TGM4 that may allow it to dampen immune activation without incurring the risk of fibrosis (<xref rid="BCJ-2025-3061F5" ref-type="fig">Figure&#160;5</xref>).</p><fig position="float" id="BCJ-2025-3061F5" fig-type="figure" orientation="portrait"><label>Figure 5</label><caption><title>Model of cell specific actions of TGM proteins.</title><p>Conceptual model comparing receptor interactions and cell specificity of TGF-&#946;, TGM4 and TGM6. Created in BioRender. McSorley, HJ. (2025) <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://BioRender.com/a55n320" ext-link-type="uri">https://BioRender.com/a55n320</ext-link> (<bold>a</bold>) TGF-&#946; acts as a homodimer to assemble a heterotetrameric complex of TGFBR1<sub>2</sub>:TGFBR2<sub>2</sub> that signal to all cells expressing these receptors. (<bold>b</bold>) TGM4 ligates co-receptors including CD44, CD49d and CD206, while directly binding TGFBR1 and TGFBR2. D4-5 of TGM4 bind to CD44 and CD206; the domain binding to CD49d has not been conclusively identified. As a result of co-receptor interactions, TGM4 is selectively active on immune cells, particularly macrophages and does not activate fibroblasts with low or no expression of these co-receptors. (<bold>c</bold>) TGM6 lacks D1-2 and so cannot bind TGFBR1; it does however bind TGFBR2 together with a co-receptor (Co-R) that is different from those identified binding to TGM1 or TGM4. When added to cells expressing the appropriate co-receptor, such as fibroblasts, TGM6 acts as an antagonist of TGF-&#946; signalling. TGF, transforming growth factor; TGM, transforming growth factor-&#946; mimics.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="BCJ-482-09-BCJ20253061-g005.jpg"/></fig></sec><sec id="s6"><title>Inhibitor discovery and diversification of TGMs in <italic toggle="yes">H. polygyrus</italic></title><p>TGM6, 9 and 10 stand out for their absence of D1-2 which, in other family members, bind TGFBR1. We hypothesised that these proteins could act as antagonists if, for example, they sequestered TGFBR2 without recruiting TGFBR1to permit its phosphorylation. Indeed, TGM6 was recently found to retain and even have enhanced binding to TGFBR2 compared with TGM1 (<italic toggle="yes">Kd</italic> 1-2 &#956;M and ~0.3 &#956;M for TGM1 and TGM6, respectively) [<xref rid="BCJ-2025-3061C36" ref-type="bibr">36</xref>,<xref rid="BCJ-2025-3061C50" ref-type="bibr">50</xref>]. TGM6 also competed with TGF-&#946; for binding TGFBR2, but it did not bind TGFBR1 or any other type I receptors of the TGF-&#946; family. In reporter assays in mouse cells, such as MFB-F11 and NIH-3T3 fibroblasts, TGM6 was found to potently inhibit signalling by either TGM1 or TGF-&#946; with sub-nanomolar potency [<xref rid="BCJ-2025-3061C50" ref-type="bibr">50</xref>]. However, TGM6 was unable to inhibit TGF-&#946; signalling in some other cell types, such as splenic T cells. The latter, together with the inability of TGM6 to bind CD44, suggests that TGM6 may require a co-receptor, presumably engaged by D4-5, that is specific to fibroblasts and other populations such as epithelial cells that can also be inhibited by TGM6, in contrast with TGM4 which is specific for immune cells through a different co-receptor profile (<xref rid="BCJ-2025-3061F5" ref-type="fig">Figure&#160;5</xref>).</p><p>TGM6, 7, 8, 9 and 10 share lower sequence similarity (28&#8211;32%) with D4-5 of TGM1 and are likely to interact with different co-receptors than TGM1. Consistent with this notion, we found that TGM6 did not bind CD44 and antagonism by TGM6 depended on the physical attachment of D3 with D4-5 [<xref rid="BCJ-2025-3061C50" ref-type="bibr">50</xref>]. Our TGM (co)receptor identification studies, with both TGM agonists and antagonists, suggest that TGMs deliver TGF-&#946; agonistic or antagonistic signals via in-cis interaction with ubiquitously expressed host TGF-&#946; receptors and cell-type selective co-receptors. Therefore, identification of co-receptors for TGM6, 7, 8, 9 and 10 and the cell populations that express these receptors is eagerly awaited.</p><p>TGM1&#8211;10 are all produced by the same species, <italic toggle="yes">H. polygyrus</italic>. One possible reason for the secretion of multiple TGMs is that TGF-&#946; is a highly contextual and multifunctional protein. Activating a TGM with similar binding and signalling characteristics to mammalian TGF-&#946; might confer benefits, but it would also likely have adverse effects and thus offer no net benefit to <italic toggle="yes">H. polygyrus</italic>. To maximise their fecundity and longevity, the modular domain structure of the TGMs has enabled <italic toggle="yes">H. polygyrus</italic> to evolve the secretion of TGMs that specifically activate or inactivate TGF-&#946; signalling in specific cell types (<xref rid="BCJ-2025-3061F5" ref-type="fig">Figure&#160;5</xref>). Our recent TGM binding studies have provided insights into how the cell-specific mechanism is achieved. The key point is that the affinities of TGMs D1-3 for signalling TGF-&#946; receptors, particularly TGFBR2, are too weak to trigger TGF-&#946; (agonistic) responses. For instance, TGM4 has more than a 100-fold lower affinity for TGFBR2 than TGF-&#946;. Moreover, TGMs D1-3 must be physically connected to D4-5 (as they are in wildtype TGMs) to elicit TGF-&#946; modulatory responses [<xref rid="BCJ-2025-3061C36" ref-type="bibr">36</xref>,<xref rid="BCJ-2025-3061C49" ref-type="bibr">49</xref>,<xref rid="BCJ-2025-3061C50" ref-type="bibr">50</xref>]. If cells are treated with a combination of TGM4&#8211;5 and truncated versions of TGM D1-3, TGM activity cannot be rescued. These findings suggest that binding TGM D4-5 to co-receptors is essential to increase cell surface avidity, above that accomplished solely by TGM D1-3 alone. The simultaneous combinatorial TGM interactions with (co-)receptors in-cis allow for the delivery of cell-specific specific responses.</p></sec><sec id="s7"><title>Evolutionary history</title><p><italic toggle="yes">H. polygyrus</italic> enhances its survival in mouse hosts by exploiting the immune suppressive pathway mediated by TGF-&#946;. It achieves this by having convergently evolved the functionally similar TGMs, which, despite primary amino acid sequences and structures being completely unrelated to that of mammalian TGF-&#946;, are nonetheless able to interact with host TGFBRs. Phylogenetic analysis (<xref rid="BCJ-2025-3061F3" ref-type="fig">Figure&#160;3b</xref>) suggests that the three domain TGMs, TGM6, 9 and 10, are the ancestors of the family [<xref rid="BCJ-2025-3061C51" ref-type="bibr">51</xref>], indicating that D3 and its ligation to TGFBR2 was an ancestral characteristic. If correct, this suggests that TGMs likely evolved to antagonise the TGF-&#946; pathway, perhaps as a mechanism to minimise fibrotic damage to the host as the parasite progresses through its life cycle in which the larvae bore though the intestinal epithelium to encyst in the muscle, and after maturation into adults, bore once again through the epithelium to the lumen to reproduce and for eggs to be excreted in the faeces.</p><p>Helminths are common parasites in humans and other animals, creating a notable interest in the presence of TGF-&#946; mimetic proteins beyond the Heligmosomidae family, which includes <italic toggle="yes">H. polygyrus</italic> and species of the <italic toggle="yes">Heligmosomum</italic> genus. Some evidence suggests an archaic precursor in the ruminant nematode <italic toggle="yes">Haemonchus contortus</italic>, which belongs to the sister family Trichostrongylidae, both within the Strongyloidea superfamily [<xref rid="BCJ-2025-3061C51" ref-type="bibr">51</xref>]. The lack of TGMs beyond <italic toggle="yes">H. polygyrus</italic> is caused by a paucity of full-length cDNA sequences and incomplete whole genome sequences for species within and beyond its own taxonomic family. It would be valuable to address this gap and investigate the presence of TGMs in species other than <italic toggle="yes">H. polygyrus</italic>.</p></sec><sec id="s8"><title>True TGF-&#946; homologues in helminths</title><p>The TGF-&#946; family is well conserved: TGF-&#946; encoding genes are identifiable across all metazoan organisms [<xref rid="BCJ-2025-3061C64" ref-type="bibr">64</xref>,<xref rid="BCJ-2025-3061C65" ref-type="bibr">65</xref>]. The model nematode <italic toggle="yes">Caenorhabditis elegans</italic> expresses five TGF-&#946; family encoded genes, DAF-7, TIG-3, DBL-1, TIG-2 and UNC-129, the first two being most closely related to TGF-&#946; [<xref rid="BCJ-2025-3061C66" ref-type="bibr">66</xref>,<xref rid="BCJ-2025-3061C67" ref-type="bibr">67</xref>]. <italic toggle="yes">C. elegans</italic> also possesses both type I (DAF-1, SMA-6) and type II (DAF-4) receptors, the latter even able to bind human BMP-2 and BMP-4 proteins [<xref rid="BCJ-2025-3061C68" ref-type="bibr">68</xref>]. In the best characterised system, the DAF4 receptor controls entry of <italic toggle="yes">C. elegans</italic> into arrested development, which is blocked in the presence of the TGF-&#946; family ligand DAF-7 [<xref rid="BCJ-2025-3061C69" ref-type="bibr">69</xref>], while more recent studies have reported a remarkable involvement of DBL-1 and TIG-2 in the innate immune response of <italic toggle="yes">C. elegans</italic> to bacterial infection [<xref rid="BCJ-2025-3061C67" ref-type="bibr">67</xref>].</p><p>Subsequently, multiple TGF-&#946; family members and their receptors have been identified across a wide range of parasitic nematodes [<xref rid="BCJ-2025-3061C70" ref-type="bibr">70&#8211;75</xref>], trematodes [<xref rid="BCJ-2025-3061C76" ref-type="bibr">76</xref>,<xref rid="BCJ-2025-3061C77" ref-type="bibr">77</xref>] and cestodes [<xref rid="BCJ-2025-3061C78" ref-type="bibr">78</xref>]. The presence of TGF-&#946; family genes across parasitic and non-parasitic helminth species implies that these genes have a developmental role in all helminths. Interestingly, while DAF-7 prevents arrested development in <italic toggle="yes">C. elegans</italic>, the role of TGF-&#946; signalling appears to be reversed in parasitic species [<xref rid="BCJ-2025-3061C79" ref-type="bibr">79</xref>]. Arrest is obligatory for larval parasitic stages until they take the opportunity to infect a new host, and in species such as the mosquito-borne <italic toggle="yes">Brugia malayi</italic>, expression of the TGF-&#946; homologue TGH-2 is maximal in blood-stage microfilariae that await uptake by the arthropod vector before recommencing development [<xref rid="BCJ-2025-3061C71" ref-type="bibr">71</xref>,<xref rid="BCJ-2025-3061C79" ref-type="bibr">79</xref>]. More broadly, genetic knockdown of TGF-&#946; family members in parasitic helminths has confirmed developmental requirements for many of these genes, with roles in trematodes in embryogenesis [<xref rid="BCJ-2025-3061C76" ref-type="bibr">76</xref>] and in the moulting and development of parasitic nematodes [<xref rid="BCJ-2025-3061C75" ref-type="bibr">75</xref>]. For example, a recombinant activin-like product of the liver fluke <italic toggle="yes">Fasciola hepatica</italic> enhanced parasite egg embryonation and parasite viability [<xref rid="BCJ-2025-3061C80" ref-type="bibr">80</xref>], while RNAi knockdown of the corresponding gene compromised the development and movement of newly excysted juvenile parasites [<xref rid="BCJ-2025-3061C81" ref-type="bibr">81</xref>].</p><p>Since this well-conserved family of proteins retains similarity to their mammalian counterparts, it would be logical to propose that gene duplication of parasite TGF-&#946; family members, and evolution to bind to host TGF-&#946; receptors could be an efficient mechanism of parasite immunomodulation [<xref rid="BCJ-2025-3061C82" ref-type="bibr">82</xref>]. Indeed, it has been reported that TGF-&#946; homologues from <italic toggle="yes">Brugia malayi</italic> (Bm-TGH-2) [<xref rid="BCJ-2025-3061C71" ref-type="bibr">71</xref>] and <italic toggle="yes">Fasciola hepatica</italic> (FhTLM) [<xref rid="BCJ-2025-3061C77" ref-type="bibr">77</xref>] may signal via host TGF-&#946; family receptors. However, when tested in T cell culture assays, no helminth homologue has been found to replicate the Foxp3<sup>+</sup> regulatory T cell expansion activity of host TGF-&#946; or TGM1 [<xref rid="BCJ-2025-3061C78" ref-type="bibr">78</xref>,<xref rid="BCJ-2025-3061C81" ref-type="bibr">81</xref>]. A TGF-&#946; homologue from <italic toggle="yes">Echinococcus multilocularis</italic> (EmACT) has been reported that is only distantly related to human TGF-&#946;, with 24% amino acid identity in the C-terminal receptor-binding region, albeit slightly higher similarity to activin. EmACT cannot directly induce Foxp3<sup>+</sup> regulatory T cells in culture, but can amplify Foxp3 induction by low concentrations of recombinant TGF-&#946; [<xref rid="BCJ-2025-3061C78" ref-type="bibr">78</xref>]. This effect is similar to that seen for mammalian activin A, which requires TGF-&#946; and TGF-&#946;-like receptor signalling to mediate its regulatory T cell-promoting effects [<xref rid="BCJ-2025-3061C83" ref-type="bibr">83</xref>].</p><p>Some unanswered questions remain about these interactions. For example, do endogenous TGF-&#946; receptors in helminths recognise and respond to host-derived ligands, as suggested by a report that exposure of adult <italic toggle="yes">S. mansoni</italic> worms to human TGF-&#946; induces a gene response that is blocked by knockdown of the parasite type II receptor [<xref rid="BCJ-2025-3061C84" ref-type="bibr">84</xref>]. Furthermore, the possibility that worm receptors can respond to the <italic toggle="yes">H. polygyrus</italic> TGMs remains to be explored.</p><p>Therefore, parasitic nematodes produce multiple TGF-&#946; family proteins, and it is possible that some may be involved in modulation of the host immune response. Further investigations are required to identify which of these TGF-&#946; family proteins are developmental, immunomodulatory or both and to ascertain their complementary TGF-&#946; family receptors. More broadly, the presence of <italic toggle="yes">bona fide</italic> helminth TGF-&#946; homologues poses the question of why <italic toggle="yes">H. polygyrus</italic> evolved the TGM family from a completely unrelated ancestor to carry out this immunomodulatory function.</p></sec><sec id="s9"><title>Other cytokine modulators from helminth parasites</title><p>The TGF-&#946; pathway is clearly a rich seam for parasite immunomodulation, but it is far from the only cytokine signalling pathway modulated by parasite secreted factors [<xref rid="BCJ-2025-3061C10" ref-type="bibr">10</xref>]. Parasite products target many cytokines that either induce or suppress type 2 immune responses, including the interleukin (IL)-13, IL-33 and macrophage migration inhibitory factor (MIF) pathways.</p><p>IL-13 is a critical effector cytokine in the type 2 immune response: although pleiotropic, it is particularly effective on stromal cells, inducing goblet and tuft cell differentiation in the intestinal tract, together with smooth muscle hyperplasia. These cellular effects increase mucus secretion and peristalsis, mediating the &#8216;weep and sweep&#8217; response for helminth ejection. In <italic toggle="yes">T. muris</italic> infection, IL-13 production is particularly key to resistance versus susceptibility [<xref rid="BCJ-2025-3061C85" ref-type="bibr">85</xref>], with IL-13-deficient mice on a resistant genetic background becoming highly susceptible to the parasite. Therefore, IL-13 seems a prime target for modulation by <italic toggle="yes">T. muris</italic>. Secretions of <italic toggle="yes">T. muris</italic> are dominated by a single protein, p43 [<xref rid="BCJ-2025-3061C86" ref-type="bibr">86</xref>], the gene for which is the tenth most highly expressed transcript in the adult parasite [<xref rid="BCJ-2025-3061C87" ref-type="bibr">87</xref>]. p43 binds directly to IL-13 and blocks the activity of this cytokine, inhibiting IL-13 responses during infection. Importantly, although p43 is not immunogenic during natural infection, vaccination with p43 in an alum adjuvant resulted in parasite ejection, thought to be due to the blockade of p43-mediated immunomodulation of IL-13 [<xref rid="BCJ-2025-3061C86" ref-type="bibr">86</xref>].</p><p>Responses to the alarmin cytokine IL-33 are also strongly implicated in immunity to helminths, with increased susceptibility of mice deficient in either IL-33 or the IL-33 receptor (ST2) seen in a wide range of helminth infections [<xref rid="BCJ-2025-3061C4" ref-type="bibr">4</xref>]. Therefore, as is the case for IL-13, the IL-33 pathway constitutes a crucial focus of helminth immunomodulation. <italic toggle="yes">H. polygyrus</italic> HES suppresses IL-33 responses in models of asthma [<xref rid="BCJ-2025-3061C88" ref-type="bibr">88</xref>,<xref rid="BCJ-2025-3061C89" ref-type="bibr">89</xref>] and in helminth infection [<xref rid="BCJ-2025-3061C90" ref-type="bibr">90</xref>] through down-regulation of ST2 transcription [<xref rid="BCJ-2025-3061C89" ref-type="bibr">89</xref>] and through inducing IL-1&#946; release, which in turn suppresses production of IL-33 and IL-25 [<xref rid="BCJ-2025-3061C90" ref-type="bibr">90</xref>]. Finally, HES contains two families of proteins that interact directly with IL-33 or ST2, respectively. The <italic toggle="yes">H. polygyrus</italic> Alarmin Release Inhibitor (HpARI) family binds directly to IL-33 [<xref rid="BCJ-2025-3061C91" ref-type="bibr">91</xref>,<xref rid="BCJ-2025-3061C92" ref-type="bibr">92</xref>]. The HpARI family contains three members (HpARI1-3), of which HpARI1 and HpARI2 suppress responses to IL-33, while HpARI3 stabilises IL-33 and amplifies responses to the cytokine [<xref rid="BCJ-2025-3061C93" ref-type="bibr">93</xref>]. It is unclear why the parasite encodes proteins that have directly opposing functions; however, an explanation may stem from the finding that while HpARI1 and HpARI2 also bind to the extracellular matrix, HpARI3 does not [<xref rid="BCJ-2025-3061C94" ref-type="bibr">94</xref>], which could result in spatial or temporal separation of their effects <italic toggle="yes">in vivo</italic>. Finally, HES also contains the Binds Alarmin Receptor and Inhibits (HpBARI) family, containing HpBARI and HpBARI_Hom2 [<xref rid="BCJ-2025-3061C95" ref-type="bibr">95</xref>]. Both HpBARIs act similarly, binding with high affinity to ST2 and blocking interaction between the cytokine and its receptor. Thus, considerable evidence indicates that <italic toggle="yes">H. polygyrus</italic> applies significant resources to suppress IL-33 pathway, indicating the importance of this cytokine in resistance to the parasite.</p><p>Remarkably, HpARI and HpBARI have also both descended from an ancestral domain and are thus distantly related to the TGM family; it appears that within the <italic toggle="yes">H. polygyrus</italic> lineage, there has been repeated duplication and expansion of -like genes so that they are highly represented in the parasite genome [<xref rid="BCJ-2025-3061C10" ref-type="bibr">10</xref>]. Thus, while no direct homologues of the HpARIs or HpBARIs have been identified in other parasites (as is also the case for TGMs), there are multiple domains encoded in all helminth genomes and it appears likely that other parasites will have adapted these for the purposes of immune evasion in one manner or another [<xref rid="BCJ-2025-3061C96" ref-type="bibr">96</xref>].</p><p>The MIF pathway, as its name suggests, is important in the activation of macrophages. Its effects are highly context-dependent, activating macrophages in inflammatory settings but also having a role in the induction of type 2 immune responses via activation of a type 2 innate lymphoid cell (ILC2)-tuft cell pathway [<xref rid="BCJ-2025-3061C97" ref-type="bibr">97</xref>]. As host MIF expression is required for optimal anti-parasite immunity [<xref rid="BCJ-2025-3061C98" ref-type="bibr">98</xref>], it is surprising that many parasitic helminths secrete MIF homologues. Indeed, the MIF family is well conserved across many organisms, whether free-living or parasitic [<xref rid="BCJ-2025-3061C99" ref-type="bibr">99</xref>]. Several parasitic helminth MIFs show immunosuppressive properties via induction of anti-inflammatory macrophage activation (<italic toggle="yes">Brugia malayi</italic> Bm-MIF1/2 [<xref rid="BCJ-2025-3061C100" ref-type="bibr">100</xref>], induction of immunosuppressive cytokines (<italic toggle="yes">Strongyloides ratti</italic> Sra-MIF [<xref rid="BCJ-2025-3061C101" ref-type="bibr">101</xref>]) or regulatory T cell recruitment (<italic toggle="yes">Anisakis simplex</italic> As-MIF [<xref rid="BCJ-2025-3061C102" ref-type="bibr">102</xref>]). With an eye to the host agonism/antagonism via the TGM and HpARI families, it would be timely to revisit this work to test whether closely related MIF homologues are agonists versus antagonists and whether like the TGMs they modulate MIF signalling in a context-specific manner that would be optimal for the parasite.</p></sec><sec id="s10"><title>Other helminth products modulating host responses</title><p>Helminths also secrete many other molecules that heavily affect host immune responses and target towards myeloid immune cells, such as DCs and macrophages. A well-studied example is the enzyme ribonuclease, omega-1, secreted by eggs of <italic toggle="yes">Schistosoma mansoni</italic> [<xref rid="BCJ-2025-3061C103" ref-type="bibr">103</xref>]. Omega-1 primed DCs for Th2 polarisation [<xref rid="BCJ-2025-3061C104" ref-type="bibr">104</xref>,<xref rid="BCJ-2025-3061C105" ref-type="bibr">105</xref>] through binding of the mannose receptor via Lewis X glycan structures. Upon internalisation in DCs, protein synthesis was inhibited [<xref rid="BCJ-2025-3061C106" ref-type="bibr">106</xref>], while omega-1 also affected inflammasome-dependent IL-1-&#946; in macrophages [<xref rid="BCJ-2025-3061C107" ref-type="bibr">107</xref>]. Experimental models showed that the administration of recombinant omega-1 <italic toggle="yes">in vivo</italic> targeted type 2 conventional DC (cDC2) and prevented allergic asthma by hampering DC migration [<xref rid="BCJ-2025-3061C108" ref-type="bibr">108</xref>]. This effect was dominant over the type 2 polarisation. Likewise, the fatty acid binding protein (FABP)1 from <italic toggle="yes">F. hepatica</italic> influenced DC function and T cell polarisation through the induction of thrombospondin-1 in DCs [<xref rid="BCJ-2025-3061C109" ref-type="bibr">109</xref>]. The molecule ES-62 is produced by the filarial nematode <italic toggle="yes">Acanthocheilonema viteae</italic> and has anti-inflammatory activities demonstrated in numerous models of inflammatory diseases [<xref rid="BCJ-2025-3061C110" ref-type="bibr">110</xref>]. ES-62 is a tetrameric glycoprotein, comprising of identical monomers of ~62 kDa and exerts its anti-inflammatory effect through a phosphorylcholine (PC)-containing moiety. ES-62 targets toll-like receptor (TLR)4 and affects downstream signalling leading to enhanced extracellular signal-regulated kinase (ERK)1/2 activation and DC hyporesponsiveness [<xref rid="BCJ-2025-3061C111" ref-type="bibr">111</xref>]. Apart from DCs, B cells are also targeted by secreted schistosome enzymes and molecules. For example, both recombinant glycoprotein antigen IPSE/&#945;1, Sm14 and Thioredoxin-1 (SmTrx-1), induced IL-10-producing regulatory B cells, instrumental in driving regulatory T cells and immune evasion [<xref rid="BCJ-2025-3061C112" ref-type="bibr">112</xref>,<xref rid="BCJ-2025-3061C113" ref-type="bibr">113</xref>].</p><p>Interestingly, an increasing number of studies suggest that helminth-derived molecules impact metabolic activity and in that manner modify the function of specific immune cells, like macrophages. For example, it was suggested that recombinant omega-1 improved whole-body metabolic homeostasis [<xref rid="BCJ-2025-3061C114" ref-type="bibr">114</xref>,<xref rid="BCJ-2025-3061C115" ref-type="bibr">115</xref>]. Another class of molecules in this context form the cystatins, cysteine protease inhibitors which are produced by numerous helminth species, including <italic toggle="yes">A. viteae, Ascaris lumbricoides, S. japonicum</italic> and <italic toggle="yes">S. mansoni</italic>. Cystatin administration shows inhibitory effects in disease models [<xref rid="BCJ-2025-3061C116" ref-type="bibr">116&#8211;118</xref>]. This may be partially regulated by enhanced mevalonate and cholesterol biosynthesis pathways and immunomodulatory gene activity in DCs and macrophages, as demonstrated for cystatins secreted by <italic toggle="yes">A. lumbricoides</italic> [<xref rid="BCJ-2025-3061C119" ref-type="bibr">119</xref>]. An immunomodulating peptide secreted by <italic toggle="yes">Fasciola hepatica,</italic> named helminth defence molecule (FhHDM)1 was able to switch macrophage metabolism to oxidative phosphorylation fuelled by fatty acids and the induction of glutaminolysis. This was accompanied by decreased tumour necrosis factor and IL-6 production pointing to a role of switched immunometabolism in immune suppression [<xref rid="BCJ-2025-3061C120" ref-type="bibr">120</xref>]. Lastly, a recent study demonstrated that helminthic glutamate dehydrogenase secreted by <italic toggle="yes">H. polygyrus</italic> actively suppresses macrophage-mediated host defence through induction of prostaglandin E2 and suppression of type 2-promoting leukotrienes via 2-hydroxyglutarate (2-HG) [<xref rid="BCJ-2025-3061C121" ref-type="bibr">121</xref>]. Increased 2-HG is associated with reprogrammed cellular metabolism and is usually linked to hypoxia and mitochondrial dysfunction. 2-HG is grouped with other tricarboxylic acid cycle metabolites, such as acetyl-CoA, itaconate, succinate, fumarate, which are known for their capacity to alter both innate and adaptive immune cell systems through their ability to modify chromatin remodelling and DNA methylation, rewiring the epigenetic landscape of immune cells [<xref rid="BCJ-2025-3061C122" ref-type="bibr">122</xref>]. We are only at the beginning of understanding how such metabolic cues can induce long-term functional consequences for immune cells and how helminths have mastered the art of manipulating these processes through the secretion of enzymes and other interference mechanisms.</p></sec><sec sec-type="conclusions" id="s11"><title>Conclusions</title><p>The example of the helminth TGMs is instructive both in scope &#8211; that parasites can evolve unprecedented ligands that target pivotal pathways in host immunity &#8211; and in strategy, for combinatorial receptor binding is an especially effective means of selectively acting on specific host cell populations. As well as specificity, multivalency bestows avidity that will always exceed the affinity of any individual ligand-receptor pair. The multi-domain TGMs extend this further with trivalent interactions, an example with few parallels in extracellular receptor biology.</p><p>There are many fascinating nuances to be gleaned from this system: for example, the moderation of affinity for the canonical TGF-&#946; receptors is key to the success of TGMs, as higher affinity would obviate the requirement for co-receptors and ablate cell specificity. Trivalency enables high avidity to be attained while maintaining individual receptor binding at low-to-medium affinity levels. Furthermore, maximal affinity does not always translate into optimal efficacy, as demonstrated in the setting of agonistic monoclonal antibodies for checkpoint immunotherapy, which act by driving a signal rather than blockade [<xref rid="BCJ-2025-3061C123" ref-type="bibr">123</xref>].</p><p>The interconversion of agonists and antagonists by gain or loss of binding modules represents a further quintessential feature of the TGM family. Mimicry to overturn function, as in the case of the antagonists, is not unique: the plant pathogen <italic toggle="yes">Phytophthora</italic> Suppressor of RNA silencing 2 protein PSR2 comprises divergent LWY modules, one of which mimics a host plant phosphatase subunit and combines with the remaining subunits to redirect its specificity to new protein targets [<xref rid="BCJ-2025-3061C124" ref-type="bibr">124</xref>].</p><p>In conclusion, TGM modularity offers exciting opportunities for exploitation in the setting of TGF-&#946; signalling: if we can recombine, redesign and repurpose agonists and antagonists to different target cells and tissues, introducing novel modules with new specificities and fine-tuning affinities for maximum discriminatory properties, we may realise the therapeutic potential of this remarkable gene family across a wide range of disease settings.</p></sec></body><back><sec sec-type="COI-statement" id="s12"><title>Competing Interests</title><p>The authors declare that there are no competing interests associated with the manuscript.</p></sec><sec sec-type="funding" id="s13"><title>Funding</title><p>This work was funded by awards to HJM, RMM and HHS from LONGFONDS|Accelerate as part of the AWWA project; the UK Medical Research Council to HJM (MR/S000593/1); the NIH through an RO1 (GM58670) and RO3 (AI53915) awarded to APH; and the Wellcome Trust through Investigator Awards awarded to RMM (Ref 219530) and HJM (Ref 221914) and a Wellcome Trust Discovery Award jointly held by all five authors (Ref 306173).</p></sec><sec sec-type="open-access" id="s14"><title>Open Access</title><p>For the purpose of open access, the authors have applied a Creative Commons Attribution (CC BY) licence to any Author Accepted Manuscript version arising from this submission.</p></sec><sec sec-type="author-contrib" id="s15"><title>CRediT Author Contribution</title><p>R.M.M., H.J.M., H.H.S., P.D., and A.P.H.: Writing&#8211;original draft and writing&#8211;review and editing.</p></sec><glossary><title>Abbreviations</title><def-list list-content="abbreviations"><def-item><term id="uid1">CCP</term><def><p>complement control protein</p></def></def-item><def-item><term id="uid2">TGF</term><def><p>transforming growth factor</p></def></def-item><def-item><term id="uid3">TGMs</term><def><p>transforming growth factor-&#223; mimics</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="BCJ-2025-3061C1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Finlay</surname><given-names>B.B.</given-names></name><name name-style="western"><surname>McFadden</surname><given-names>G</given-names></name></person-group><year>2006</year><article-title>Anti-immunology: evasion of the host immune system by bacterial and viral pathogens</article-title><source>Cell</source><volume>124</volume><fpage>767</fpage><lpage>782</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2006.01.034</pub-id><pub-id pub-id-type="pmid">16497587</pub-id></element-citation></ref><ref id="BCJ-2025-3061C2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmid-Hempel</surname><given-names>P</given-names></name></person-group><year>2008</year><article-title>Parasite immune evasion: a momentous molecular war. trends ecol evol.</article-title><volume>23</volume><fpage>318</fpage><lpage>326</lpage><pub-id pub-id-type="doi">10.1016/j.tree.2008.02.011</pub-id><pub-id pub-id-type="pmid">18439709</pub-id></element-citation></ref><ref id="BCJ-2025-3061C3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maizels</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Yazdanbakhsh</surname><given-names>M</given-names></name></person-group><year>2003</year><article-title>Regulation of the immune response by helminth parasites: cellular and molecular mechanisms</article-title><source>Nat. Rev. Immunol.</source><volume>3</volume><fpage>733</fpage><lpage>744</lpage><pub-id pub-id-type="doi">10.1038/nri1183</pub-id><pub-id pub-id-type="pmid">12949497</pub-id></element-citation></ref><ref id="BCJ-2025-3061C4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McSorley</surname><given-names>H.J.</given-names></name><name name-style="western"><surname>Smyth</surname><given-names>D.J</given-names></name></person-group><year>2021</year><article-title>IL-33 : A central cytokine in helminth infections</article-title><source>Semin. Immunol.</source><volume>53</volume><fpage>101532</fpage><pub-id pub-id-type="doi">10.1016/j.smim.2021.101532</pub-id><pub-id pub-id-type="pmid">34823996</pub-id></element-citation></ref><ref id="BCJ-2025-3061C5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mayer</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Fried</surname><given-names>B</given-names></name></person-group><year>2007</year><article-title>The role of helminth infections in carcinogenesis</article-title><source>Adv. Parasitol.</source><volume>65</volume><fpage>239</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1016/S0065-308X(07)65004-0</pub-id><pub-id pub-id-type="pmid">18063098</pub-id></element-citation></ref><ref id="BCJ-2025-3061C6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Natukunda</surname><given-names>A.</given-names></name><name name-style="western"><surname>Zirimenya</surname><given-names>L.</given-names></name><name name-style="western"><surname>Nassuuna</surname><given-names>J.</given-names></name><name name-style="western"><surname>Nkurunungi</surname><given-names>G.</given-names></name><name name-style="western"><surname>Cose</surname><given-names>S.</given-names></name><name name-style="western"><surname>Elliott</surname><given-names>A.M.</given-names></name><etal>et al.</etal></person-group><year>2022</year><article-title>The effect of helminth infection on vaccine responses in humans and animal models: a systematic review and meta-analysis</article-title><source>Parasite Immunol.</source><volume>44</volume><elocation-id>e12939</elocation-id><pub-id pub-id-type="doi">10.1111/pim.12939</pub-id><pub-id pub-id-type="pmid">35712983</pub-id><pub-id pub-id-type="pmcid">PMC9542036</pub-id></element-citation></ref><ref id="BCJ-2025-3061C7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Acharya</surname><given-names>S.</given-names></name><name name-style="western"><surname>Da&#8217;dara</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Skelly</surname><given-names>P.J</given-names></name></person-group><year>2022</year><article-title>Schistosome immunomodulators</article-title><source>Plos Pathog.</source><volume>17</volume><elocation-id>e1010064</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1010064</pub-id><pub-id pub-id-type="pmcid">PMC8718004</pub-id><pub-id pub-id-type="pmid">34969052</pub-id></element-citation></ref><ref id="BCJ-2025-3061C8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bobardt</surname><given-names>S.D.</given-names></name><name name-style="western"><surname>Dillman</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Nair</surname><given-names>M.G</given-names></name></person-group><year>2020</year><article-title>The two faces of nematode infection: virulence and immunomodulatory molecules from nematode parasites of insects and mammals</article-title><source>Front. Microbiol.</source><volume>11</volume><elocation-id>577846</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2020.577846</pub-id><pub-id pub-id-type="pmid">33343521</pub-id><pub-id pub-id-type="pmcid">PMC7738434</pub-id></element-citation></ref><ref id="BCJ-2025-3061C9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harnett</surname><given-names>W</given-names></name></person-group><year>2014</year><article-title>Secretory products of helminth parasites as immunomodulators</article-title><source>Mol. Biochem. Parasitol.</source><volume>195</volume><fpage>130</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1016/j.molbiopara.2014.03.007</pub-id><pub-id pub-id-type="pmid">24704440</pub-id></element-citation></ref><ref id="BCJ-2025-3061C10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maizels</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Smits</surname><given-names>H.H.</given-names></name><name name-style="western"><surname>McSorley</surname><given-names>H.J</given-names></name></person-group><year>2018</year><article-title>Modulation of host immunity by helminths: the expanding repertoire of parasite effector molecules</article-title><source>Immunity</source><volume>49</volume><fpage>801</fpage><lpage>818</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2018.10.016</pub-id><pub-id pub-id-type="pmid">30462997</pub-id><pub-id pub-id-type="pmcid">PMC6269126</pub-id></element-citation></ref><ref id="BCJ-2025-3061C11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ryan</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Eichenberger</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Ruscher</surname><given-names>R.</given-names></name><name name-style="western"><surname>Giacomin</surname><given-names>P.R.</given-names></name><name name-style="western"><surname>Loukas</surname><given-names>A</given-names></name></person-group><year>2020</year><article-title>Harnessing helminth-driven immunoregulation in the search for novel therapeutic modalities</article-title><source>Plos Pathog.</source><volume>16</volume><elocation-id>e1008508</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1008508</pub-id><pub-id pub-id-type="pmid">32407385</pub-id><pub-id pub-id-type="pmcid">PMC7224462</pub-id></element-citation></ref><ref id="BCJ-2025-3061C12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lambrecht</surname><given-names>B.N.</given-names></name><name name-style="western"><surname>Hammad</surname><given-names>H.</given-names></name><name name-style="western"><surname>Fahy</surname><given-names>J.V</given-names></name></person-group><year>2019</year><article-title>The cytokines of asthma</article-title><source>Immunity</source><volume>50</volume><fpage>975</fpage><lpage>991</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2019.03.018</pub-id><pub-id pub-id-type="pmid">30995510</pub-id></element-citation></ref><ref id="BCJ-2025-3061C13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leonard</surname><given-names>W.J.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>J.X.</given-names></name><name name-style="western"><surname>O&#8217;Shea</surname><given-names>J.J</given-names></name></person-group><year>2019</year><article-title>The &#947;<sub>c</sub> family of cytokines: basic biology to therapeutic ramifications</article-title><source>Immunity</source><volume>50</volume><fpage>832</fpage><lpage>850</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2019.03.028</pub-id><pub-id pub-id-type="pmid">30995502</pub-id></element-citation></ref><ref id="BCJ-2025-3061C14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mantovani</surname><given-names>A.</given-names></name><name name-style="western"><surname>Dinarello</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Molgora</surname><given-names>M.</given-names></name><name name-style="western"><surname>Garlanda</surname><given-names>C</given-names></name></person-group><year>2019</year><article-title>Interleukin-1 and related cytokines in the regulation of inflammation and immunity</article-title><source>Immunity</source><volume>50</volume><fpage>778</fpage><lpage>795</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2019.03.012</pub-id><pub-id pub-id-type="pmid">30995499</pub-id><pub-id pub-id-type="pmcid">PMC7174020</pub-id></element-citation></ref><ref id="BCJ-2025-3061C15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McGeachy</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Cua</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Gaffen</surname><given-names>S.L</given-names></name></person-group><year>2019</year><article-title>The IL-17 family of cytokines in health and disease</article-title><source>Immunity</source><volume>50</volume><fpage>892</fpage><lpage>906</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2019.03.021</pub-id><pub-id pub-id-type="pmid">30995505</pub-id><pub-id pub-id-type="pmcid">PMC6474359</pub-id></element-citation></ref><ref id="BCJ-2025-3061C16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Massagu&#233;</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sheppard</surname><given-names>D</given-names></name></person-group><year>2023</year><article-title>TGF-&#946; signaling in health and disease</article-title><source>Cell</source><volume>186</volume><fpage>4007</fpage><lpage>4037</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2023.07.036</pub-id><pub-id pub-id-type="pmid">37714133</pub-id><pub-id pub-id-type="pmcid">PMC10772989</pub-id></element-citation></ref><ref id="BCJ-2025-3061C17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Richardson</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wilcockson</surname><given-names>S.G.</given-names></name><name name-style="western"><surname>Guglielmi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Hill</surname><given-names>C.S</given-names></name></person-group><year>2023</year><article-title>Context-dependent TGF&#946; family signalling in cell fate regulation</article-title><source>Nat. Rev. Mol. Cell Biol.</source><volume>24</volume><fpage>876</fpage><lpage>894</lpage><pub-id pub-id-type="doi">10.1038/s41580-023-00638-3</pub-id><pub-id pub-id-type="pmid">37596501</pub-id></element-citation></ref><ref id="BCJ-2025-3061C18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>M.O.</given-names></name><name name-style="western"><surname>Wan</surname><given-names>Y.Y.</given-names></name><name name-style="western"><surname>Sanjabi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Robertson</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Flavell</surname><given-names>R.A</given-names></name></person-group><year>2006</year><article-title>Transforming growth factor-&#946; regulation of immune responses</article-title><source>Annu. Rev. Immunol.</source><volume>24</volume><fpage>99</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.24.021605.090737</pub-id><pub-id pub-id-type="pmid">16551245</pub-id></element-citation></ref><ref id="BCJ-2025-3061C19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kulkarni</surname><given-names>A.B.</given-names></name><name name-style="western"><surname>Thyagarajan</surname><given-names>T.</given-names></name><name name-style="western"><surname>Letterio</surname><given-names>J.J</given-names></name></person-group><year>2002</year><article-title>Function of cytokines within the TGF-&#946; superfamily as determined from transgenic and gene knockout studies in mice</article-title><source>Curr. Mol. Med.</source><volume>2</volume><fpage>303</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.2174/1566524024605699</pub-id><pub-id pub-id-type="pmid">12041733</pub-id></element-citation></ref><ref id="BCJ-2025-3061C20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sanford</surname><given-names>L.P.</given-names></name><name name-style="western"><surname>Ormsby</surname><given-names>I.</given-names></name><name name-style="western"><surname>Gittenberger-de Groot</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Sariola</surname><given-names>H.</given-names></name><name name-style="western"><surname>Friedman</surname><given-names>R.</given-names></name><name name-style="western"><surname>Boivin</surname><given-names>G.P.</given-names></name><etal>et al.</etal></person-group><year>1997</year><article-title>TGF&#946;2 knockout mice have multiple developmental defects that are non-overlapping with other TGF&#946; knockout phenotypes</article-title><source>Development</source><volume>124</volume><fpage>2659</fpage><lpage>2670</lpage><pub-id pub-id-type="doi">10.1242/dev.124.13.2659</pub-id><pub-id pub-id-type="pmid">9217007</pub-id><pub-id pub-id-type="pmcid">PMC3850286</pub-id></element-citation></ref><ref id="BCJ-2025-3061C21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaartinen</surname><given-names>V.</given-names></name><name name-style="western"><surname>Voncken</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Shuler</surname><given-names>C.</given-names></name><name name-style="western"><surname>Warburton</surname><given-names>D.</given-names></name><name name-style="western"><surname>Bu</surname><given-names>D.</given-names></name><name name-style="western"><surname>Heisterkamp</surname><given-names>N.</given-names></name><etal>et al.</etal></person-group><year>1995</year><article-title>Abnormal lung development and cleft palate in mice lacking TGF-&#946; 3 indicates defects of epithelial-mesenchymal interaction</article-title><source>Nat. Genet.</source><volume>11</volume><fpage>415</fpage><lpage>421</lpage><pub-id pub-id-type="doi">10.1038/ng1295-415</pub-id><pub-id pub-id-type="pmid">7493022</pub-id></element-citation></ref><ref id="BCJ-2025-3061C22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ten Dijke</surname><given-names>P</given-names></name></person-group><year>2021</year><article-title>Therapeutic targeting of TGF-&#946; in cancer: hacking a master switch of immune suppression</article-title><source>Clin. Sci. (Lond)</source><volume>135</volume><fpage>35</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1042/CS20201236</pub-id><pub-id pub-id-type="pmid">33399850</pub-id><pub-id pub-id-type="pmcid">PMC7796313</pub-id></element-citation></ref><ref id="BCJ-2025-3061C23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tauriello</surname><given-names>D.V.F.</given-names></name><name name-style="western"><surname>Palomo-Ponce</surname><given-names>S.</given-names></name><name name-style="western"><surname>Stork</surname><given-names>D.</given-names></name><name name-style="western"><surname>Berenguer-Llergo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Badia-Ramentol</surname><given-names>J.</given-names></name><name name-style="western"><surname>Iglesias</surname><given-names>M.</given-names></name><etal>et al.</etal></person-group><year>2018</year><article-title>TGF&#946; drives immune evasion in genetically reconstituted colon cancer metastasis</article-title><source>Nature</source><volume>554</volume><fpage>538</fpage><lpage>543</lpage><pub-id pub-id-type="doi">10.1038/nature25492</pub-id><pub-id pub-id-type="pmid">29443964</pub-id></element-citation></ref><ref id="BCJ-2025-3061C24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mariathasan</surname><given-names>S.</given-names></name><name name-style="western"><surname>Turley</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Nickles</surname><given-names>D.</given-names></name><name name-style="western"><surname>Castiglioni</surname><given-names>A.</given-names></name><name name-style="western"><surname>Yuen</surname><given-names>K.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><etal>et al.</etal></person-group><year>2018</year><article-title>TGF&#946; attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells</article-title><source>Nature</source><volume>554</volume><fpage>544</fpage><lpage>548</lpage><pub-id pub-id-type="doi">10.1038/nature25501</pub-id><pub-id pub-id-type="pmid">29443960</pub-id><pub-id pub-id-type="pmcid">PMC6028240</pub-id></element-citation></ref><ref id="BCJ-2025-3061C25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maizels</surname><given-names>R.M</given-names></name></person-group><year>2021</year><article-title>The multi-faceted roles of TGF-&#946; in regulation of immunity to infection</article-title><source>Adv. Immunol.</source><volume>150</volume><fpage>1</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1016/bs.ai.2021.05.001</pub-id><pub-id pub-id-type="pmid">34176558</pub-id></element-citation></ref><ref id="BCJ-2025-3061C26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doetze</surname><given-names>A.</given-names></name><name name-style="western"><surname>Satoguina</surname><given-names>J.</given-names></name><name name-style="western"><surname>Burchard</surname><given-names>G.</given-names></name><name name-style="western"><surname>Rau</surname><given-names>T.</given-names></name><name name-style="western"><surname>L&#246;liger</surname><given-names>C.</given-names></name><name name-style="western"><surname>Fleischer</surname><given-names>B.</given-names></name><etal>et al.</etal></person-group><year>2000</year><article-title>Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by Th3/Tr1-type cytokines IL-10 and transforming growth factor-&#946; but not by a Th1 to Th2 shift</article-title><source>Int. Immunol.</source><volume>12</volume><fpage>623</fpage><lpage>630</lpage><pub-id pub-id-type="doi">10.1093/intimm/12.5.623</pub-id><pub-id pub-id-type="pmid">10784608</pub-id></element-citation></ref><ref id="BCJ-2025-3061C27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ara&#250;jo-Jorge</surname><given-names>T.C.</given-names></name><name name-style="western"><surname>Waghabi</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Soeiro</surname><given-names>M. de N.C.</given-names></name><name name-style="western"><surname>Keramidas</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bailly</surname><given-names>S.</given-names></name><name name-style="western"><surname>Feige</surname><given-names>J.J</given-names></name></person-group><year>2008</year><article-title>Pivotal role for TGF-&#946; in infectious heart disease: the case of <italic toggle="yes">Trypanosoma cruzi</italic> infection and consequent chagasic myocardiopathy</article-title><source>Cytokine Growth Factor Rev.</source><volume>19</volume><fpage>405</fpage><lpage>413</lpage><pub-id pub-id-type="doi">10.1016/j.cytogfr.2008.08.002</pub-id><pub-id pub-id-type="pmid">18938102</pub-id></element-citation></ref><ref id="BCJ-2025-3061C28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grainger</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Hewitson</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>McSorley</surname><given-names>H.J.</given-names></name><name name-style="western"><surname>Harcus</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Filbey</surname><given-names>K.J.</given-names></name><etal>et al.</etal></person-group><year>2010</year><article-title>Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-&#946; pathway</article-title><source>J. Exp. Med.</source><volume>207</volume><fpage>2331</fpage><lpage>2341</lpage><pub-id pub-id-type="doi">10.1084/jem.20101074</pub-id><pub-id pub-id-type="pmid">20876311</pub-id><pub-id pub-id-type="pmcid">PMC2964568</pub-id></element-citation></ref><ref id="BCJ-2025-3061C29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Worthington</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Klementowicz</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Rahman</surname><given-names>S.</given-names></name><name name-style="western"><surname>Czajkowska</surname><given-names>B.I.</given-names></name><name name-style="western"><surname>Smedley</surname><given-names>C.</given-names></name><name name-style="western"><surname>Waldmann</surname><given-names>H.</given-names></name><etal>et al.</etal></person-group><year>2013</year><article-title>Loss of the TGF&#946;-activating integrin &#945;v&#946;8 on dendritic cells protects mice from chronic intestinal parasitic infection via control of type 2 immunity</article-title><source>Plos Pathog.</source><volume>9</volume><elocation-id>e1003675</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003675</pub-id><pub-id pub-id-type="pmid">24098124</pub-id><pub-id pub-id-type="pmcid">PMC3789784</pub-id></element-citation></ref><ref id="BCJ-2025-3061C30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Filbey</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Reynolds</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Hewitson</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Harcus</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Boon</surname><given-names>L.</given-names></name><etal>et al.</etal></person-group><year>2016</year><article-title>Low-level regulatory T-cell activity is essential for functional type-2 effector immunity to expel gastrointestinal helminths</article-title><source>Mucosal Immunol.</source><volume>9</volume><fpage>428</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1038/mi.2015.73</pub-id><pub-id pub-id-type="pmid">26286232</pub-id><pub-id pub-id-type="pmcid">PMC4677460</pub-id></element-citation></ref><ref id="BCJ-2025-3061C31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hartmann</surname><given-names>W.</given-names></name><name name-style="western"><surname>Schramm</surname><given-names>C.</given-names></name><name name-style="western"><surname>Breloer</surname><given-names>M</given-names></name></person-group><year>2015</year><article-title><italic toggle="yes">Litomosoides sigmodontis</italic> induces TGF-&#946; receptor responsive, IL-10-producing T cells that suppress bystander T-cell proliferation in mice</article-title><source>Eur. J. Immunol.</source><volume>45</volume><fpage>2568</fpage><lpage>2581</lpage><pub-id pub-id-type="doi">10.1002/eji.201545503</pub-id><pub-id pub-id-type="pmid">26138667</pub-id></element-citation></ref><ref id="BCJ-2025-3061C32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hewitson</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Harcus</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Murray</surname><given-names>J.</given-names></name><name name-style="western"><surname>van Agtmaal,</surname><given-names>M.</given-names></name><name name-style="western"><surname>Filbey</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Grainger</surname><given-names>J.R.</given-names></name><etal>et al.</etal></person-group><year>2011</year><article-title>Proteomic analysis of secretory products from the model gastrointestinal nematode <italic toggle="yes">Heligmosomoides polygyrus</italic> reveals dominance of venom allergen-like (VAL) proteins</article-title><source>J. Proteomics</source><volume>74</volume><fpage>1573</fpage><lpage>1594</lpage><pub-id pub-id-type="doi">10.1016/j.jprot.2011.06.002</pub-id><pub-id pub-id-type="pmid">21722761</pub-id><pub-id pub-id-type="pmcid">PMC4794625</pub-id></element-citation></ref><ref id="BCJ-2025-3061C33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hewitson</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Ivens</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Harcus</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Filbey</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>McSorley</surname><given-names>H.J.</given-names></name><name name-style="western"><surname>Murray</surname><given-names>J.</given-names></name><etal>et al.</etal></person-group><year>2013</year><article-title>Secretion of protective antigens by tissue-stage nematode larvae revealed by proteomic analysis and vaccination-induced sterile immunity</article-title><source>Plos Pathog.</source><volume>9</volume><elocation-id>e1003492</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003492</pub-id><pub-id pub-id-type="pmid">23966853</pub-id><pub-id pub-id-type="pmcid">PMC3744408</pub-id></element-citation></ref><ref id="BCJ-2025-3061C34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnston</surname><given-names>C.J.C.</given-names></name><name name-style="western"><surname>Smyth</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Kodali</surname><given-names>R.B.</given-names></name><name name-style="western"><surname>White</surname><given-names>M.P.J.</given-names></name><name name-style="western"><surname>Harcus</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Filbey</surname><given-names>K.J.</given-names></name><etal>et al.</etal></person-group><year>2017</year><article-title>A structurally distinct TGF-&#946; mimic from an intestinal helminth parasite potently induces regulatory T cells</article-title><source>Nat. Commun.</source><volume>8</volume><fpage>1741</fpage><pub-id pub-id-type="doi">10.1038/s41467-017-01886-6</pub-id><pub-id pub-id-type="pmid">29170498</pub-id><pub-id pub-id-type="pmcid">PMC5701006</pub-id></element-citation></ref><ref id="BCJ-2025-3061C35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hinck</surname><given-names>A.P.</given-names></name><name name-style="western"><surname>Mueller</surname><given-names>T.D.</given-names></name><name name-style="western"><surname>Springer</surname><given-names>T.A</given-names></name></person-group><year>2016</year><article-title>Structural biology and evolution of the TGF-&#946; family</article-title><source>Cold Spring Harb. Perspect. Biol.</source><volume>8</volume><elocation-id>a022103</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a022103</pub-id><pub-id pub-id-type="pmid">27638177</pub-id><pub-id pub-id-type="pmcid">PMC5131774</pub-id></element-citation></ref><ref id="BCJ-2025-3061C36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mukundan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Byeon</surname><given-names>C.H.</given-names></name><name name-style="western"><surname>Hinck</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Cunningham</surname><given-names>K.</given-names></name><name name-style="western"><surname>Campion</surname><given-names>T.</given-names></name><name name-style="western"><surname>Smyth</surname><given-names>D.J.</given-names></name><etal>et al.</etal></person-group><year>2022</year><article-title>Convergent evolution of a parasite-encoded complement control protein-scaffold to mimic binding of mammalian TGF-&#946; to its receptors, T&#946;RI and T&#946;RII</article-title><source>J. Biol. Chem.</source><volume>298</volume><elocation-id>101994</elocation-id><pub-id pub-id-type="doi">10.1016/j.jbc.2022.101994</pub-id><pub-id pub-id-type="pmid">35500648</pub-id><pub-id pub-id-type="pmcid">PMC9163516</pub-id></element-citation></ref><ref id="BCJ-2025-3061C37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li&#233;nart</surname><given-names>S.</given-names></name><name name-style="western"><surname>Merceron</surname><given-names>R.</given-names></name><name name-style="western"><surname>Vanderaa</surname><given-names>C.</given-names></name><name name-style="western"><surname>Lambert</surname><given-names>F.</given-names></name><name name-style="western"><surname>Colau</surname><given-names>D.</given-names></name><name name-style="western"><surname>Stockis</surname><given-names>J.</given-names></name><etal>et al.</etal></person-group><year>2018</year><article-title>Structural basis of latent TGF-&#946;1 presentation and activation by GARP on human regulatory T cells</article-title><source>Science</source><volume>362</volume><fpage>952</fpage><lpage>956</lpage><pub-id pub-id-type="doi">10.1126/science.aau2909</pub-id><pub-id pub-id-type="pmid">30361387</pub-id></element-citation></ref><ref id="BCJ-2025-3061C38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>R.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name><name name-style="western"><surname>Mi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Walz</surname><given-names>T.</given-names></name><etal>et al.</etal></person-group><year>2011</year><article-title>Latent TGF-&#946; structure and activation</article-title><source>Nature</source><volume>474</volume><fpage>343</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.1038/nature10152</pub-id><pub-id pub-id-type="pmid">21677751</pub-id><pub-id pub-id-type="pmcid">PMC4717672</pub-id></element-citation></ref><ref id="BCJ-2025-3061C39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>White</surname><given-names>M.P.J.</given-names></name><name name-style="western"><surname>Smyth</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Cook</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ziegler</surname><given-names>S.F.</given-names></name><name name-style="western"><surname>Levings</surname><given-names>M.K.</given-names></name><name name-style="western"><surname>Maizels</surname><given-names>R.M</given-names></name></person-group><year>2021</year><article-title>The parasite cytokine mimic Hp-TGM potently replicates the regulatory effects of TGF-&#946; on murine CD4<sup>+</sup> T cells</article-title><source>Immunol. Cell Biol.</source><volume>99</volume><fpage>848</fpage><lpage>864</lpage><pub-id pub-id-type="doi">10.1111/imcb.12479</pub-id><pub-id pub-id-type="pmid">33988885</pub-id><pub-id pub-id-type="pmcid">PMC9214624</pub-id></element-citation></ref><ref id="BCJ-2025-3061C40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cook</surname><given-names>L.</given-names></name><name name-style="western"><surname>Reid</surname><given-names>K.T.</given-names></name><name name-style="western"><surname>H&#228;kkinen</surname><given-names>E.</given-names></name><name name-style="western"><surname>de Bie,</surname><given-names>B.</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>S.</given-names></name><name name-style="western"><surname>Smyth</surname><given-names>D.J.</given-names></name><etal>et al.</etal></person-group><year>2021</year><article-title>Induction of stable human FOXP3<sup>+</sup> Tregs by a parasite-derived TGF-&#946; mimic</article-title><source>Immunol. Cell Biol.</source><volume>99</volume><fpage>833</fpage><lpage>847</lpage><pub-id pub-id-type="doi">10.1111/imcb.12475</pub-id><pub-id pub-id-type="pmid">33929751</pub-id><pub-id pub-id-type="pmcid">PMC8453874</pub-id></element-citation></ref><ref id="BCJ-2025-3061C41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lothstein</surname><given-names>K.E.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>F.</given-names></name><name name-style="western"><surname>Mishra</surname><given-names>P.</given-names></name><name name-style="western"><surname>Smyth</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Lemenze</surname><given-names>A.</given-names></name><etal>et al.</etal></person-group><year>2024</year><article-title>Helminth protein enhances wound healing by inhibiting fibrosis and promoting tissue regeneration</article-title><source>Life Sci. Alliance</source><volume>7</volume><elocation-id>e202302249</elocation-id><pub-id pub-id-type="doi">10.26508/lsa.202302249</pub-id><pub-id pub-id-type="pmid">39179288</pub-id><pub-id pub-id-type="pmcid">PMC11342954</pub-id></element-citation></ref><ref id="BCJ-2025-3061C42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smyth</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>White</surname><given-names>M.P.J.</given-names></name><name name-style="western"><surname>Johnston</surname><given-names>C.J.C.</given-names></name><name name-style="western"><surname>Donachie</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Campillo Poveda</surname><given-names>M.</given-names></name><name name-style="western"><surname>McSorley</surname><given-names>H.J.</given-names></name><etal>et al.</etal></person-group><year>2023</year><article-title>Protection from T cell-dependent colitis by the helminth-derived immunomodulatory mimic of transforming growth factor-&#946;, <italic toggle="yes">Hp</italic>-TGM</article-title><source>Discov. Immunol.</source><volume>2</volume><elocation-id>kyad001</elocation-id><pub-id pub-id-type="doi">10.1093/discim/kyad001</pub-id><pub-id pub-id-type="pmid">36855464</pub-id><pub-id pub-id-type="pmcid">PMC9958376</pub-id></element-citation></ref><ref id="BCJ-2025-3061C43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chauch&#233;</surname><given-names>C.</given-names></name><name name-style="western"><surname>Rasid</surname><given-names>O.</given-names></name><name name-style="western"><surname>Donachie</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>McManus</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>L&#246;ser</surname><given-names>S.</given-names></name><name name-style="western"><surname>Campion</surname><given-names>T.</given-names></name><etal>et al.</etal></person-group><year>2022</year><article-title>Suppression of airway allergic eosinophilia by Hp-TGM, a helminth mimic of TGF-&#946;</article-title><source>Immunology</source><volume>167</volume><fpage>197</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1111/imm.13528</pub-id><pub-id pub-id-type="pmid">35758054</pub-id><pub-id pub-id-type="pmcid">PMC9885513</pub-id></element-citation></ref><ref id="BCJ-2025-3061C44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>L&#243;pez-Casillas</surname><given-names>F.</given-names></name><name name-style="western"><surname>Wrana</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Massagu&#233;</surname><given-names>J</given-names></name></person-group><year>1993</year><article-title>Betaglycan presents ligand to the TGF-&#946; signaling receptor</article-title><source>Cell</source><volume>73</volume><fpage>1435</fpage><lpage>1444</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(93)90368-z</pub-id><pub-id pub-id-type="pmid">8391934</pub-id></element-citation></ref><ref id="BCJ-2025-3061C45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kanamori</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nakatsukasa</surname><given-names>H.</given-names></name><name name-style="western"><surname>Okada</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Yoshimura</surname><given-names>A</given-names></name></person-group><year>2016</year><article-title>Induced regulatory T cells: their development, stability, and applications</article-title><source>Trends Immunol.</source><volume>37</volume><fpage>803</fpage><lpage>811</lpage><pub-id pub-id-type="doi">10.1016/j.it.2016.08.012</pub-id><pub-id pub-id-type="pmid">27623114</pub-id></element-citation></ref><ref id="BCJ-2025-3061C46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smyth</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Ren</surname><given-names>B.</given-names></name><name name-style="western"><surname>White</surname><given-names>M.P.J.</given-names></name><name name-style="western"><surname>McManus</surname><given-names>C.</given-names></name><name name-style="western"><surname>Webster</surname><given-names>H.</given-names></name><name name-style="western"><surname>Shek</surname><given-names>V.</given-names></name><etal>et al.</etal></person-group><year>2021</year><article-title>Oral delivery of a functional algal-expressed TGF-&#946; mimic halts colitis in a murine DSS model</article-title><source>J. Biotechnol.</source><volume>340</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1016/j.jbiotec.2021.08.006</pub-id><pub-id pub-id-type="pmid">34390759</pub-id><pub-id pub-id-type="pmcid">PMC8516079</pub-id></element-citation></ref><ref id="BCJ-2025-3061C47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Redgrave</surname><given-names>R.E.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>E.</given-names></name><name name-style="western"><surname>Tual-Chalot</surname><given-names>S.</given-names></name><name name-style="western"><surname>Park</surname><given-names>C.</given-names></name><name name-style="western"><surname>Hall</surname><given-names>D.</given-names></name><name name-style="western"><surname>Bennaceur</surname><given-names>K.</given-names></name><etal>et al.</etal></person-group><year>2024</year><article-title>Exogenous transforming growth factor-&#946;1 and its helminth-derived mimic attenuate the heart&#8217;s inflammatory ersponse to ischemic injury and reduce mature scar size</article-title><source>Am. J. Pathol.</source><volume>194</volume><fpage>562</fpage><lpage>573</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2023.09.014</pub-id><pub-id pub-id-type="pmid">37832870</pub-id><pub-id pub-id-type="pmcid">PMC12178337</pub-id></element-citation></ref><ref id="BCJ-2025-3061C48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smyth</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Harcus</surname><given-names>Y.</given-names></name><name name-style="western"><surname>White</surname><given-names>M.P.J.</given-names></name><name name-style="western"><surname>Gregory</surname><given-names>W.F.</given-names></name><name name-style="western"><surname>Nahler</surname><given-names>J.</given-names></name><name name-style="western"><surname>Stephens</surname><given-names>I.</given-names></name><etal>et al.</etal></person-group><year>2018</year><article-title>TGF-&#946; mimic proteins form an extended gene family in the murine parasite <italic toggle="yes">Heligmosomoides polygyrus</italic></article-title><source>Int. J. Parasitol.</source><volume>48</volume><fpage>379</fpage><lpage>385</lpage><pub-id pub-id-type="doi">10.1016/j.ijpara.2017.12.004</pub-id><pub-id pub-id-type="pmid">29510118</pub-id><pub-id pub-id-type="pmcid">PMC5904571</pub-id></element-citation></ref><ref id="BCJ-2025-3061C49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>S.P.</given-names></name><name name-style="western"><surname>Smyth</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Cunningham</surname><given-names>K.T.</given-names></name><name name-style="western"><surname>Mukundan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Byeon</surname><given-names>C.H.</given-names></name><name name-style="western"><surname>Hinck</surname><given-names>C.S.</given-names></name><etal>et al.</etal></person-group><year>2025</year><article-title>The TGF-&#946; mimic TGM4 achieves cell specificity through combinatorial surface co-receptor binding</article-title><source>EMBO Rep.</source><volume>26</volume><fpage>218</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1038/s44319-024-00323-2</pub-id><pub-id pub-id-type="pmid">39609640</pub-id><pub-id pub-id-type="pmcid">PMC11723922</pub-id></element-citation></ref><ref id="BCJ-2025-3061C50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>White</surname><given-names>S.E.</given-names></name><name name-style="western"><surname>Schwartze</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Mukundan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Schoenherr</surname><given-names>C.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>S.P.</given-names></name><name name-style="western"><surname>van Dinther,</surname><given-names>M.</given-names></name><etal>et al.</etal></person-group><year>2025</year><article-title>TGM6 is a helminth secretory product that mimics TGF-&#946; binding to TGFBR2 to antagonize signaling in fibroblasts</article-title><source>Nat. Commun.</source><volume>16</volume><fpage>1847</fpage><pub-id pub-id-type="doi">10.1038/s41467-025-56954-z</pub-id><pub-id pub-id-type="pmid">39984487</pub-id><pub-id pub-id-type="pmcid">PMC11845725</pub-id></element-citation></ref><ref id="BCJ-2025-3061C51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maizels</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Newfeld</surname><given-names>S.J</given-names></name></person-group><year>2023</year><article-title>Convergent evolution in a murine intestinal parasite rapidly created the TGM family of molecular mimics to suppress the host immune response</article-title><source>Genome Biol. Evol.</source><volume>15</volume><elocation-id>evad158</elocation-id><pub-id pub-id-type="doi">10.1093/gbe/evad158</pub-id><pub-id pub-id-type="pmid">37625791</pub-id><pub-id pub-id-type="pmcid">PMC10516467</pub-id></element-citation></ref><ref id="BCJ-2025-3061C52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maruszewska-Cheruiyot</surname><given-names>M.</given-names></name><name name-style="western"><surname>Szewczak</surname><given-names>L.</given-names></name><name name-style="western"><surname>Krawczak-W&#243;jcik</surname><given-names>K.</given-names></name><name name-style="western"><surname>G&#322;aczy&#324;ska</surname><given-names>M.</given-names></name><name name-style="western"><surname>Donskow-&#321;ysoniewska</surname><given-names>K</given-names></name></person-group><year>2021</year><article-title>The production of excretory-secretory molecules from <italic toggle="yes">Heligmosomoides polygyrus bakeri</italic> fourth stage larvae varies between mixed and single sex cultures</article-title><source>Parasit. Vectors</source><volume>14</volume><fpage>106</fpage><pub-id pub-id-type="doi">10.1186/s13071-021-04613-9</pub-id><pub-id pub-id-type="pmid">33557937</pub-id><pub-id pub-id-type="pmcid">PMC7871589</pub-id></element-citation></ref><ref id="BCJ-2025-3061C53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Groppe</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hinck</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Samavarchi-Tehrani</surname><given-names>P.</given-names></name><name name-style="western"><surname>Zubieta</surname><given-names>C.</given-names></name><name name-style="western"><surname>Schuermann</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>A.B.</given-names></name><etal>et al.</etal></person-group><year>2008</year><article-title>Cooperative assembly of TGF-&#946; superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding</article-title><source>Mol. Cell</source><volume>29</volume><fpage>157</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2007.11.039</pub-id><pub-id pub-id-type="pmid">18243111</pub-id></element-citation></ref><ref id="BCJ-2025-3061C54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Dinther,</surname><given-names>M.</given-names></name><name name-style="western"><surname>Cunningham</surname><given-names>K.T.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>S.P.</given-names></name><name name-style="western"><surname>White</surname><given-names>M.P.J.</given-names></name><name name-style="western"><surname>Campion</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ciancia</surname><given-names>C.</given-names></name><etal>et al.</etal></person-group><year>2023</year><article-title>CD44 acts as a coreceptor for cell-specific enhancement of signaling and regulatory T cell induction by TGM1, a parasite TGF-&#946; mimic</article-title><source>Proc. Natl. Acad. Sci. U.S.A.</source><volume>120</volume><elocation-id>e2302370120</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2302370120</pub-id><pub-id pub-id-type="pmid">37590410</pub-id><pub-id pub-id-type="pmcid">PMC10450677</pub-id></element-citation></ref><ref id="BCJ-2025-3061C55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DeGrendele</surname><given-names>H.C.</given-names></name><name name-style="western"><surname>Estess</surname><given-names>P.</given-names></name><name name-style="western"><surname>Picker</surname><given-names>L.J.</given-names></name><name name-style="western"><surname>Siegelman</surname><given-names>MH</given-names></name></person-group><year>1996</year><article-title>CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway</article-title><source>J. Exp. Med.</source><volume>183</volume><fpage>1119</fpage><lpage>1130</lpage><pub-id pub-id-type="doi">10.1084/jem.183.3.1119</pub-id><pub-id pub-id-type="pmid">8642254</pub-id><pub-id pub-id-type="pmcid">PMC2192320</pub-id></element-citation></ref><ref id="BCJ-2025-3061C56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ponta</surname><given-names>H.</given-names></name><name name-style="western"><surname>Sherman</surname><given-names>L.</given-names></name><name name-style="western"><surname>Herrlich</surname><given-names>P.A</given-names></name></person-group><year>2003</year><article-title>CD44: from adhesion molecules to signalling regulators</article-title><source>Nat. Rev. Mol. Cell Biol.</source><volume>4</volume><fpage>33</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1038/nrm1004</pub-id><pub-id pub-id-type="pmid">12511867</pub-id></element-citation></ref><ref id="BCJ-2025-3061C57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Budd</surname><given-names>R.C.</given-names></name><name name-style="western"><surname>Cerottini</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Horvath</surname><given-names>C.</given-names></name><name name-style="western"><surname>Bron</surname><given-names>C.</given-names></name><name name-style="western"><surname>Pedrazzini</surname><given-names>T.</given-names></name><name name-style="western"><surname>Howe</surname><given-names>R.C.</given-names></name><etal>et al.</etal></person-group><year>1987</year><article-title>Distinction of virgin and memory T lymphocytes. stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation</article-title><source>J. Immunol.</source><volume>138</volume><fpage>3120</fpage><lpage>3129</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.138.10.3120</pub-id><pub-id pub-id-type="pmid">3106474</pub-id></element-citation></ref><ref id="BCJ-2025-3061C58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walter</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Sonnentag</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Munoz-Sagredo</surname><given-names>L.</given-names></name><name name-style="western"><surname>Merkel</surname><given-names>M.</given-names></name><name name-style="western"><surname>Richert</surname><given-names>L.</given-names></name><name name-style="western"><surname>Bunert</surname><given-names>F.</given-names></name><etal>et al.</etal></person-group><year>2022</year><article-title>Wnt signaling is boosted during intestinal regeneration by a CD44-positive feedback loop</article-title><source>Cell Death Dis.</source><volume>13</volume><fpage>168</fpage><pub-id pub-id-type="doi">10.1038/s41419-022-04607-0</pub-id><pub-id pub-id-type="pmid">35190527</pub-id><pub-id pub-id-type="pmcid">PMC8861016</pub-id></element-citation></ref><ref id="BCJ-2025-3061C59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laiho</surname><given-names>M.</given-names></name><name name-style="western"><surname>Weis</surname><given-names>M.B.</given-names></name><name name-style="western"><surname>Massagu&#233;</surname><given-names>J</given-names></name></person-group><year>1990</year><article-title>Concomitant loss of transforming growth factor (TGF)-&#946; receptor types I and II in TGF-&#946;-resistant cell mutants implicates both receptor types in signal transduction</article-title><source>J. Biol. Chem.</source><volume>265</volume><fpage>18518</fpage><lpage>18524</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(17)44782-X</pub-id><pub-id pub-id-type="pmid">2170414</pub-id></element-citation></ref><ref id="BCJ-2025-3061C60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>H.Y.</given-names></name><name name-style="western"><surname>Moustakas</surname><given-names>A.</given-names></name><name name-style="western"><surname>Knaus</surname><given-names>P.</given-names></name><name name-style="western"><surname>Wells</surname><given-names>R.G.</given-names></name><name name-style="western"><surname>Henis</surname><given-names>Y.I.</given-names></name><name name-style="western"><surname>Lodish</surname><given-names>H.F</given-names></name></person-group><year>1995</year><article-title>The soluble exoplasmic domain of the type II transforming growth factor (TGF)-&#946; receptor. a heterogeneously glycosylated protein with high affinity and selectivity for TGF-&#946; ligands</article-title><source>J. Biol. Chem.</source><volume>270</volume><fpage>2747</fpage><lpage>2754</lpage><pub-id pub-id-type="doi">10.1074/jbc.270.6.2747</pub-id><pub-id pub-id-type="pmid">7852346</pub-id></element-citation></ref><ref id="BCJ-2025-3061C61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stenvers</surname><given-names>K.L.</given-names></name><name name-style="western"><surname>Tursky</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Harder</surname><given-names>K.W.</given-names></name><name name-style="western"><surname>Kountouri</surname><given-names>N.</given-names></name><name name-style="western"><surname>Amatayakul-Chantler</surname><given-names>S.</given-names></name><name name-style="western"><surname>Grail</surname><given-names>D.</given-names></name><etal>et al.</etal></person-group><year>2003</year><article-title>Heart and liver defects and reduced transforming growth factor &#946;2 sensitivity in transforming growth factor &#946; type III receptor-deficient embryos</article-title><source>Mol. Cell. Biol.</source><volume>23</volume><fpage>4371</fpage><lpage>4385</lpage><pub-id pub-id-type="doi">10.1128/MCB.23.12.4371-4385.2003</pub-id><pub-id pub-id-type="pmid">12773577</pub-id><pub-id pub-id-type="pmcid">PMC156130</pub-id></element-citation></ref><ref id="BCJ-2025-3061C62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheifetz</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hernandez</surname><given-names>H.</given-names></name><name name-style="western"><surname>Laiho</surname><given-names>M.</given-names></name><name name-style="western"><surname>ten Dijke,</surname><given-names>P.</given-names></name><name name-style="western"><surname>Iwata</surname><given-names>K.K.</given-names></name><name name-style="western"><surname>Massagu&#233;</surname><given-names>J</given-names></name></person-group><year>1990</year><article-title>Distinct transforming growth factor-&#946; (TGF-&#946;) receptor subsets as determinants of cellular responsiveness to three TGF-&#946; isoforms</article-title><source>J. Biol. Chem.</source><volume>265</volume><fpage>20533</fpage><lpage>20538</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(17)30535-5</pub-id><pub-id pub-id-type="pmid">1700790</pub-id></element-citation></ref><ref id="BCJ-2025-3061C63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wieteska</surname><given-names>L.</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>A.B.</given-names></name><name name-style="western"><surname>Punch</surname><given-names>E.</given-names></name><name name-style="western"><surname>Coleman</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Conway</surname><given-names>I.O.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Y.F.</given-names></name><etal>et al.</etal></person-group><year>2025</year><article-title>Structures of TGF-&#946; with betaglycan and signaling receptors reveal mechanisms of complex assembly and signaling</article-title><source>Nat. Commun.</source><volume>16</volume><fpage>1778</fpage><pub-id pub-id-type="doi">10.1038/s41467-025-56796-9</pub-id><pub-id pub-id-type="pmid">40011426</pub-id><pub-id pub-id-type="pmcid">PMC11865472</pub-id></element-citation></ref><ref id="BCJ-2025-3061C64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Herpin</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lelong</surname><given-names>C.</given-names></name><name name-style="western"><surname>Favrel</surname><given-names>P</given-names></name></person-group><year>2004</year><article-title>Transforming growth factor-&#946;-related proteins: an ancestral and widespread superfamily of cytokines in metazoans</article-title><source>Dev. Comp. Immunol.</source><volume>28</volume><fpage>461</fpage><lpage>485</lpage><pub-id pub-id-type="doi">10.1016/j.dci.2003.09.007</pub-id><pub-id pub-id-type="pmid">15062644</pub-id></element-citation></ref><ref id="BCJ-2025-3061C65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huminiecki</surname><given-names>L.</given-names></name><name name-style="western"><surname>Goldovsky</surname><given-names>L.</given-names></name><name name-style="western"><surname>Freilich</surname><given-names>S.</given-names></name><name name-style="western"><surname>Moustakas</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ouzounis</surname><given-names>C.</given-names></name><name name-style="western"><surname>Heldin</surname><given-names>CH</given-names></name></person-group><year>2009</year><article-title>Emergence, development and diversification of the TGF-&#946; signalling pathway within the animal kingdom</article-title><source>BMC Evol. Biol.</source><volume>9</volume><fpage>28</fpage><pub-id pub-id-type="doi">10.1186/1471-2148-9-28</pub-id><pub-id pub-id-type="pmid">19192293</pub-id><pub-id pub-id-type="pmcid">PMC2657120</pub-id></element-citation></ref><ref id="BCJ-2025-3061C66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gumienny</surname><given-names>T.L.</given-names></name><name name-style="western"><surname>Savage-Dunn</surname><given-names>C</given-names></name></person-group><year>2013</year><article-title>TGF-&#946; signaling in <italic toggle="yes">C. elegans</italic></article-title><source>WormBook</source><volume>2013</volume><fpage>1</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1895/wormbook.1.22.2</pub-id><pub-id pub-id-type="pmcid">PMC5081272</pub-id><pub-id pub-id-type="pmid">23908056</pub-id></element-citation></ref><ref id="BCJ-2025-3061C67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ciccarelli</surname><given-names>E.J.</given-names></name><name name-style="western"><surname>Wing</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Bendelstein</surname><given-names>M.</given-names></name><name name-style="western"><surname>Johal</surname><given-names>R.K.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>G.</given-names></name><name name-style="western"><surname>Monas</surname><given-names>A.</given-names></name><etal>et al.</etal></person-group><year>2024</year><article-title>TGF-&#946; ligand cross-subfamily interactions in the response of <italic toggle="yes">Caenorhabditis elegans</italic> to a bacterial pathogen</article-title><source>Plos Genet.</source><volume>20</volume><elocation-id>e1011324</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1011324</pub-id><pub-id pub-id-type="pmid">38875298</pub-id><pub-id pub-id-type="pmcid">PMC11210861</pub-id></element-citation></ref><ref id="BCJ-2025-3061C68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Estevez</surname><given-names>M.</given-names></name><name name-style="western"><surname>Attisano</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wrana</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Albert</surname><given-names>P.S.</given-names></name><name name-style="western"><surname>Massagu&#233;</surname><given-names>J.</given-names></name><name name-style="western"><surname>Riddle</surname><given-names>D.L</given-names></name></person-group><year>1993</year><article-title>The <italic toggle="yes">daf-4</italic> gene encodes a bone morphogenetic protein receptor controlling <italic toggle="yes">C. elegans</italic> dauer larva development</article-title><source>Nature</source><volume>365</volume><fpage>644</fpage><lpage>649</lpage><pub-id pub-id-type="doi">10.1038/365644a0</pub-id><pub-id pub-id-type="pmid">8413626</pub-id></element-citation></ref><ref id="BCJ-2025-3061C69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ren</surname><given-names>P.</given-names></name><name name-style="western"><surname>Lim</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Johnsen</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Albert</surname><given-names>P.S.</given-names></name><name name-style="western"><surname>Pilgrim</surname><given-names>D.</given-names></name><name name-style="western"><surname>Riddle</surname><given-names>D.L</given-names></name></person-group><year>1996</year><article-title>Control of <italic toggle="yes">C. elegans</italic> larval development by neuronal expression of a TGF-&#946; homolog</article-title><source>Science</source><volume>274</volume><fpage>1389</fpage><lpage>1391</lpage><pub-id pub-id-type="doi">10.1126/science.274.5291.1389</pub-id><pub-id pub-id-type="pmid">8910282</pub-id></element-citation></ref><ref id="BCJ-2025-3061C70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gomez-Escobar</surname><given-names>N.</given-names></name><name name-style="western"><surname>van den Biggelaar,</surname><given-names>A.</given-names></name><name name-style="western"><surname>Maizels</surname><given-names>R</given-names></name></person-group><year>1997</year><article-title>A member of the TGF-&#946; receptor gene family in the parasitic nematode <italic toggle="yes">Brugia pahangi</italic></article-title><source>Gene</source><volume>199</volume><fpage>101</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1016/s0378-1119(97)00353-3</pub-id><pub-id pub-id-type="pmid">9358045</pub-id></element-citation></ref><ref id="BCJ-2025-3061C71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gomez-Escobar</surname><given-names>N.</given-names></name><name name-style="western"><surname>Gregory</surname><given-names>W.F.</given-names></name><name name-style="western"><surname>Maizels</surname><given-names>R.M</given-names></name></person-group><year>2000</year><article-title>Identification of tgh-2, a filarial nematode homolog of <italic toggle="yes">Caenorhabditis elegans daf-7</italic> and human transforming growth factor &#946;, expressed in microfilarial and adult stages of <italic toggle="yes">Brugia malayi</italic></article-title><source>Infect. Immun.</source><volume>68</volume><fpage>6402</fpage><lpage>6410</lpage><pub-id pub-id-type="doi">10.1128/IAI.68.11.6402-6410.2000</pub-id><pub-id pub-id-type="pmid">11035752</pub-id><pub-id pub-id-type="pmcid">PMC97726</pub-id></element-citation></ref><ref id="BCJ-2025-3061C72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Freitas</surname><given-names>T.C.</given-names></name><name name-style="western"><surname>Arasu</surname><given-names>P</given-names></name></person-group><year>2005</year><article-title>Cloning and characterisation of genes encoding two transforming growth factor-&#946;-like ligands from the hookworm, <italic toggle="yes">Ancylostoma caninum</italic></article-title><source>Int. J. Parasitol.</source><volume>35</volume><fpage>1477</fpage><lpage>1487</lpage><pub-id pub-id-type="doi">10.1016/j.ijpara.2005.07.005</pub-id><pub-id pub-id-type="pmid">16140304</pub-id></element-citation></ref><ref id="BCJ-2025-3061C73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McSorley</surname><given-names>H.J.</given-names></name><name name-style="western"><surname>Grainger</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Harcus</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Murray</surname><given-names>J.</given-names></name><name name-style="western"><surname>Nisbet</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Knox</surname><given-names>D.P.</given-names></name><etal>et al.</etal></person-group><year>2010</year><article-title><italic toggle="yes">daf-7</italic>-related TGF-&#946; homologues from Trichostrongyloid nematodes show contrasting life-cycle expression patterns</article-title><source>Parasitology</source><volume>137</volume><fpage>159</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1017/S0031182009990321</pub-id><pub-id pub-id-type="pmid">19712539</pub-id><pub-id pub-id-type="pmcid">PMC4794624</pub-id></element-citation></ref><ref id="BCJ-2025-3061C74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>L.</given-names></name><name name-style="western"><surname>Gasser</surname><given-names>R.B.</given-names></name><name name-style="western"><surname>Li</surname><given-names>T.</given-names></name><name name-style="western"><surname>Di</surname><given-names>W.</given-names></name><name name-style="western"><surname>Li</surname><given-names>F.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name><etal>et al.</etal></person-group><year>2019</year><article-title>A TGF-&#946; type II receptor that associates with developmental transition in <italic toggle="yes">Haemonchus contortus in vitro</italic></article-title><source>Plos Negl. Trop. Dis.</source><volume>13</volume><elocation-id>e0007913</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0007913</pub-id><pub-id pub-id-type="pmid">31790412</pub-id><pub-id pub-id-type="pmcid">PMC6938378</pub-id></element-citation></ref><ref id="BCJ-2025-3061C75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>L.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>B.Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>F.F.</given-names></name><name name-style="western"><surname>Di</surname><given-names>W.D.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C.Q.</given-names></name><etal>et al.</etal></person-group><year>2020</year><article-title>A <italic toggle="yes">daf-7</italic>-related TGF-&#946; ligand (<italic toggle="yes">Hc-tgh-2</italic>) shows important regulations on the development of <italic toggle="yes">Haemonchus contortus</italic></article-title><source>Parasit. Vectors</source><volume>13</volume><fpage>326</fpage><pub-id pub-id-type="doi">10.1186/s13071-020-04196-x</pub-id><pub-id pub-id-type="pmid">32586367</pub-id><pub-id pub-id-type="pmcid">PMC7318536</pub-id></element-citation></ref><ref id="BCJ-2025-3061C76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Freitas</surname><given-names>T.C.</given-names></name><name name-style="western"><surname>Jung</surname><given-names>E.</given-names></name><name name-style="western"><surname>Pearce</surname><given-names>E.J</given-names></name></person-group><year>2007</year><article-title>TGF-&#946; signaling controls embryo development in the parasitic flatworm <italic toggle="yes">Schistosoma mansoni</italic></article-title><source>Plos Pathog.</source><volume>3</volume><elocation-id>e52</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.0030052</pub-id><pub-id pub-id-type="pmid">17411340</pub-id><pub-id pub-id-type="pmcid">PMC1847691</pub-id></element-citation></ref><ref id="BCJ-2025-3061C77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sulaiman</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Zolnierczyk</surname><given-names>K.</given-names></name><name name-style="western"><surname>Japa</surname><given-names>O.</given-names></name><name name-style="western"><surname>Owen</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Maddison</surname><given-names>B.C.</given-names></name><name name-style="western"><surname>Emes</surname><given-names>R.D.</given-names></name><etal>et al.</etal></person-group><year>2016</year><article-title>A trematode parasite derived growth factor binds and exerts influences on host immune functions via host cytokine receptor complexes</article-title><source>Plos Pathog.</source><volume>12</volume><elocation-id>e1005991</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1005991</pub-id><pub-id pub-id-type="pmid">27806135</pub-id><pub-id pub-id-type="pmcid">PMC5091765</pub-id></element-citation></ref><ref id="BCJ-2025-3061C78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nono</surname><given-names>J.K.</given-names></name><name name-style="western"><surname>Lutz</surname><given-names>M.B.</given-names></name><name name-style="western"><surname>Brehm</surname><given-names>KR</given-names></name></person-group><year>2020</year><article-title>Expansion of host regulatory T cells by secreted products of the tapeworm <italic toggle="yes">Echinococcus multilocularis</italic></article-title><source>Front. Immunol.</source><volume>11</volume><fpage>798</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2020.00798</pub-id><pub-id pub-id-type="pmid">32457746</pub-id><pub-id pub-id-type="pmcid">PMC7225322</pub-id></element-citation></ref><ref id="BCJ-2025-3061C79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Viney</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>F.J.</given-names></name><name name-style="western"><surname>Crook</surname><given-names>M</given-names></name></person-group><year>2005</year><article-title>TGF-&#946; and the evolution of nematode parasitism</article-title><source>Int. J. Parasitol.</source><volume>35</volume><fpage>1473</fpage><lpage>1475</lpage><pub-id pub-id-type="doi">10.1016/j.ijpara.2005.07.006</pub-id><pub-id pub-id-type="pmid">16139836</pub-id></element-citation></ref><ref id="BCJ-2025-3061C80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Japa</surname><given-names>O.</given-names></name><name name-style="western"><surname>Hodgkinson</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Emes</surname><given-names>R.D.</given-names></name><name name-style="western"><surname>Flynn</surname><given-names>RJ</given-names></name></person-group><year>2015</year><article-title>TGF-&#946; superfamily members from the helminth <italic toggle="yes">Fasciola hepatica</italic> show intrinsic effects on viability and development</article-title><source>Vet. Res.</source><volume>46</volume><fpage>29</fpage><pub-id pub-id-type="doi">10.1186/s13567-015-0167-2</pub-id><pub-id pub-id-type="pmid">25879787</pub-id><pub-id pub-id-type="pmcid">PMC4354977</pub-id></element-citation></ref><ref id="BCJ-2025-3061C81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Musah-Eroje</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hoyle</surname><given-names>R.C.</given-names></name><name name-style="western"><surname>Japa</surname><given-names>O.</given-names></name><name name-style="western"><surname>Hodgkinson</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Haig</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Flynn</surname><given-names>R.J</given-names></name></person-group><year>2021</year><article-title>A host-independent role for <italic toggle="yes">Fasciola hepatica</italic> transforming growth factor-like molecule in parasite development</article-title><source>Int. J. Parasitol.</source><volume>51</volume><fpage>481</fpage><lpage>492</lpage><pub-id pub-id-type="doi">10.1016/j.ijpara.2020.11.005</pub-id><pub-id pub-id-type="pmid">33581140</pub-id></element-citation></ref><ref id="BCJ-2025-3061C82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnston</surname><given-names>C.J.C.</given-names></name><name name-style="western"><surname>Smyth</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Dresser</surname><given-names>D.W.</given-names></name><name name-style="western"><surname>Maizels</surname><given-names>R.M</given-names></name></person-group><year>2016</year><article-title>TGF-&#946; in tolerance, development and regulation of immunity</article-title><source>Cell. Immunol.</source><volume>299</volume><fpage>14</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/j.cellimm.2015.10.006</pub-id><pub-id pub-id-type="pmid">26617281</pub-id><pub-id pub-id-type="pmcid">PMC4711336</pub-id></element-citation></ref><ref id="BCJ-2025-3061C83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huber</surname><given-names>S.</given-names></name><name name-style="western"><surname>Stahl</surname><given-names>F.R.</given-names></name><name name-style="western"><surname>Schrader</surname><given-names>J.</given-names></name><name name-style="western"><surname>L&#252;th</surname><given-names>S.</given-names></name><name name-style="western"><surname>Presser</surname><given-names>K.</given-names></name><name name-style="western"><surname>Carambia</surname><given-names>A.</given-names></name><etal>et al.</etal></person-group><year>2009</year><article-title>Activin a promotes the TGF-&#946;-induced conversion of CD4&#8314;CD25&#8315; T cells into Foxp3&#8314; induced regulatory T cells</article-title><source>J. Immunol.</source><volume>182</volume><fpage>4633</fpage><lpage>4640</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0803143</pub-id><pub-id pub-id-type="pmid">19342638</pub-id></element-citation></ref><ref id="BCJ-2025-3061C84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Osman</surname><given-names>A.</given-names></name><name name-style="western"><surname>Niles</surname><given-names>E.G.</given-names></name><name name-style="western"><surname>Verjovski-Almeida</surname><given-names>S.</given-names></name><name name-style="western"><surname>LoVerde</surname><given-names>P.T</given-names></name></person-group><year>2006</year><article-title><italic toggle="yes">Schistosoma mansoni</italic> TGF-&#946; receptor II: role in host ligand-induced regulation of a schistosome target gene</article-title><source>Plos Pathog</source><volume>2</volume><elocation-id>e54</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.0020054</pub-id><pub-id pub-id-type="pmid">16789838</pub-id><pub-id pub-id-type="pmcid">PMC1479047</pub-id></element-citation></ref><ref id="BCJ-2025-3061C85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bancroft</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>McKenzie</surname><given-names>A.N.J.</given-names></name><name name-style="western"><surname>Grencis</surname><given-names>R.K</given-names></name></person-group><year>1998</year><article-title>A critical role for IL-13 in resistance to intestinal nematode infection</article-title><source>J. Immunol.</source><volume>160</volume><fpage>3453</fpage><lpage>3461</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.160.7.3453</pub-id><pub-id pub-id-type="pmid">9531306</pub-id></element-citation></ref><ref id="BCJ-2025-3061C86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bancroft</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Levy</surname><given-names>C.W.</given-names></name><name name-style="western"><surname>Jowitt</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Hayes</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mckenzie</surname><given-names>E.A.</given-names></name><etal>et al.</etal></person-group><year>2019</year><article-title>The major secreted protein of the whipworm parasite tethers to matrix and inhibits interleukin-13 function</article-title><source>Nat. Commun.</source><volume>10</volume><fpage>2344</fpage><pub-id pub-id-type="doi">10.1038/s41467-019-09996-z</pub-id><pub-id pub-id-type="pmid">31138806</pub-id><pub-id pub-id-type="pmcid">PMC6538607</pub-id></element-citation></ref><ref id="BCJ-2025-3061C87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Foth</surname><given-names>B.J.</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>I.J.</given-names></name><name name-style="western"><surname>Reid</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Bancroft</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Nichol</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tracey</surname><given-names>A.</given-names></name><etal>et al.</etal></person-group><year>2014</year><article-title>Whipworm genome and dual-species transcriptome analyses provide molecular insights into an intimate host-parasite interaction</article-title><source>Nat. Genet.</source><volume>46</volume><fpage>693</fpage><lpage>700</lpage><pub-id pub-id-type="doi">10.1038/ng.3010</pub-id><pub-id pub-id-type="pmid">24929830</pub-id><pub-id pub-id-type="pmcid">PMC5012510</pub-id></element-citation></ref><ref id="BCJ-2025-3061C88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McSorley</surname><given-names>H.J.</given-names></name><name name-style="western"><surname>Blair</surname><given-names>N.F.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>McKenzie</surname><given-names>A.N.J.</given-names></name><name name-style="western"><surname>Maizels</surname><given-names>R.M</given-names></name></person-group><year>2014</year><article-title>Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy</article-title><source>Mucosal Immunol.</source><volume>7</volume><fpage>1068</fpage><lpage>1078</lpage><pub-id pub-id-type="doi">10.1038/mi.2013.123</pub-id><pub-id pub-id-type="pmid">24496315</pub-id><pub-id pub-id-type="pmcid">PMC4016792</pub-id></element-citation></ref><ref id="BCJ-2025-3061C89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coakley</surname><given-names>G.</given-names></name><name name-style="western"><surname>McCaskill</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Borger</surname><given-names>J.G.</given-names></name><name name-style="western"><surname>Simbari</surname><given-names>F.</given-names></name><name name-style="western"><surname>Robertson</surname><given-names>E.</given-names></name><name name-style="western"><surname>Millar</surname><given-names>M.</given-names></name><etal>et al.</etal></person-group><year>2017</year><article-title>Extracellular vesicles from a helminth parasite suppress macrophage activation and constitute an effective vaccine for protective immunity</article-title><source>Cell Rep.</source><volume>19</volume><fpage>1545</fpage><lpage>1557</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.05.001</pub-id><pub-id pub-id-type="pmid">28538175</pub-id><pub-id pub-id-type="pmcid">PMC5457486</pub-id></element-citation></ref><ref id="BCJ-2025-3061C90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zaiss</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Maslowski</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Mosconi</surname><given-names>I.</given-names></name><name name-style="western"><surname>Guenat</surname><given-names>N.</given-names></name><name name-style="western"><surname>Marsland</surname><given-names>B.J.</given-names></name><name name-style="western"><surname>Harris</surname><given-names>N.L</given-names></name></person-group><year>2013</year><article-title>IL-1&#946; suppresses innate IL-25 and IL-33 production and maintains helminth chronicity</article-title><source>Plos Pathog.</source><volume>9</volume><elocation-id>e1003531</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003531</pub-id><pub-id pub-id-type="pmid">23935505</pub-id><pub-id pub-id-type="pmcid">PMC3731249</pub-id></element-citation></ref><ref id="BCJ-2025-3061C91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jamwal</surname><given-names>A.</given-names></name><name name-style="western"><surname>Colomb</surname><given-names>F.</given-names></name><name name-style="western"><surname>McSorley</surname><given-names>H.J.</given-names></name><name name-style="western"><surname>Higgins</surname><given-names>M.K</given-names></name></person-group><year>2024</year><article-title>Structural basis for IL-33 recognition and its antagonism by the helminth effector protein HpARI2</article-title><source>Nat. Commun.</source><volume>15</volume><fpage>5226</fpage><pub-id pub-id-type="doi">10.1038/s41467-024-49550-0</pub-id><pub-id pub-id-type="pmid">38890291</pub-id><pub-id pub-id-type="pmcid">PMC11189471</pub-id></element-citation></ref><ref id="BCJ-2025-3061C92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Osbourn</surname><given-names>M.</given-names></name><name name-style="western"><surname>Soares</surname><given-names>D.C.</given-names></name><name name-style="western"><surname>Vacca</surname><given-names>F.</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>E.S.</given-names></name><name name-style="western"><surname>Scott</surname><given-names>I.C.</given-names></name><name name-style="western"><surname>Gregory</surname><given-names>W.F.</given-names></name><etal>et al.</etal></person-group><year>2017</year><article-title>HpARI protein secreted by a helminth parasite suppresses interleukin-33</article-title><source>Immunity</source><volume>47</volume><fpage>739</fpage><lpage>751</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2017.09.015</pub-id><pub-id pub-id-type="pmid">29045903</pub-id><pub-id pub-id-type="pmcid">PMC5655542</pub-id></element-citation></ref><ref id="BCJ-2025-3061C93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Colomb</surname><given-names>F.</given-names></name><name name-style="western"><surname>Ogunkanbi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Jamwal</surname><given-names>A.</given-names></name><name name-style="western"><surname>Dong</surname><given-names>B.</given-names></name><name name-style="western"><surname>Maizels</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Finney</surname><given-names>C.A.M.</given-names></name><etal>et al.</etal></person-group><year>2024</year><article-title>IL-33-binding HpARI family homologues with divergent effects in suppressing or enhancing type 2 immune responses</article-title><source>Infect. Immun.</source><volume>92</volume><elocation-id>e00395-23</elocation-id><pub-id pub-id-type="doi">10.1128/iai.00395-23</pub-id><pub-id pub-id-type="pmid">38294241</pub-id><pub-id pub-id-type="pmcid">PMC10929406</pub-id></element-citation></ref><ref id="BCJ-2025-3061C94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Colomb</surname><given-names>F.</given-names></name><name name-style="western"><surname>Jamwal</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ogunkanbi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Frangova</surname><given-names>T.</given-names></name><name name-style="western"><surname>Savage</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>S.</given-names></name><etal>et al.</etal></person-group><year>2024</year><article-title>Heparan sulphate binding controls in vivo half-life of the HpARI protein family</article-title><source>Elife</source><volume>13</volume><elocation-id>RP99000</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.99000</pub-id><pub-id pub-id-type="pmid">39514278</pub-id><pub-id pub-id-type="pmcid">PMC11548879</pub-id></element-citation></ref><ref id="BCJ-2025-3061C95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vacca</surname><given-names>F.</given-names></name><name name-style="western"><surname>Chauch&#233;</surname><given-names>C.</given-names></name><name name-style="western"><surname>Jamwal</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hinchy</surname><given-names>E.C.</given-names></name><name name-style="western"><surname>Heieis</surname><given-names>G.</given-names></name><name name-style="western"><surname>Webster</surname><given-names>H.</given-names></name><etal>et al.</etal></person-group><year>2020</year><article-title>A helminth-derived suppressor of ST2 blocks allergic responses</article-title><source>Elife</source><volume>9</volume><elocation-id>e54017</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.54017</pub-id><pub-id pub-id-type="pmid">32420871</pub-id><pub-id pub-id-type="pmcid">PMC7234810</pub-id></element-citation></ref><ref id="BCJ-2025-3061C96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Colomb</surname><given-names>F.</given-names></name><name name-style="western"><surname>McSorley</surname><given-names>H.J</given-names></name></person-group><year>2025</year><article-title>Protein families secreted by nematodes to modulate host immunity</article-title><source>Curr. Opin. Microbiol.</source><volume>84</volume><elocation-id>102582</elocation-id><pub-id pub-id-type="doi">10.1016/j.mib.2025.102582</pub-id><pub-id pub-id-type="pmid">39954371</pub-id></element-citation></ref><ref id="BCJ-2025-3061C97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Varyani</surname><given-names>F.</given-names></name><name name-style="western"><surname>L&#246;ser</surname><given-names>S.</given-names></name><name name-style="western"><surname>Filbey</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Harcus</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Drurey</surname><given-names>C.</given-names></name><name name-style="western"><surname>Poveda</surname><given-names>M.C.</given-names></name><etal>et al.</etal></person-group><year>2022</year><article-title>The IL-25-dependent tuft cell circuit driven by intestinal helminths requires macrophage migration inhibitory factor (MIF)</article-title><source>Mucosal Immunol.</source><volume>15</volume><fpage>1243</fpage><lpage>1256</lpage><pub-id pub-id-type="doi">10.1038/s41385-022-00496-w</pub-id><pub-id pub-id-type="pmid">35288645</pub-id><pub-id pub-id-type="pmcid">PMC9705247</pub-id></element-citation></ref><ref id="BCJ-2025-3061C98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Filbey</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Varyani</surname><given-names>F.</given-names></name><name name-style="western"><surname>Harcus</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hewitson</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Smyth</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>McSorley</surname><given-names>H.J.</given-names></name><etal>et al.</etal></person-group><year>2019</year><article-title>Macrophage migration inhibitory factor (MIF) is essential for type 2 effector cell immunity to an intestinal helminth parasite</article-title><source>Front. Immunol.</source><volume>10</volume><elocation-id>2375</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2019.02375</pub-id><pub-id pub-id-type="pmid">31708913</pub-id><pub-id pub-id-type="pmcid">PMC6821780</pub-id></element-citation></ref><ref id="BCJ-2025-3061C99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sparkes</surname><given-names>A.</given-names></name><name name-style="western"><surname>De Baetselier</surname><given-names>P.</given-names></name><name name-style="western"><surname>Roelants</surname><given-names>K.</given-names></name><name name-style="western"><surname>De Trez</surname><given-names>C.</given-names></name><name name-style="western"><surname>Magez</surname><given-names>S.</given-names></name><name name-style="western"><surname>Van Ginderachter</surname><given-names>J.A.</given-names></name><etal>et al.</etal></person-group><year>2017</year><article-title>The non-mammalian MIF superfamily</article-title><source>Immunobiology</source><volume>222</volume><fpage>473</fpage><lpage>482</lpage><pub-id pub-id-type="doi">10.1016/j.imbio.2016.10.006</pub-id><pub-id pub-id-type="pmid">27780588</pub-id><pub-id pub-id-type="pmcid">PMC5293613</pub-id></element-citation></ref><ref id="BCJ-2025-3061C100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prieto-Lafuente</surname><given-names>L.</given-names></name><name name-style="western"><surname>Gregory</surname><given-names>W.F.</given-names></name><name name-style="western"><surname>Allen</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Maizels</surname><given-names>R.M</given-names></name></person-group><year>2009</year><article-title>MIF homologues from a filarial nematode parasite synergize with IL-4 to induce alternative activation of host macrophages</article-title><source>J. Leukoc. Biol.</source><volume>85</volume><fpage>844</fpage><lpage>854</lpage><pub-id pub-id-type="doi">10.1189/jlb.0808459</pub-id><pub-id pub-id-type="pmid">19179453</pub-id><pub-id pub-id-type="pmcid">PMC2691607</pub-id></element-citation></ref><ref id="BCJ-2025-3061C101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Younis</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Soblik</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ajonina-Ekoti</surname><given-names>I.</given-names></name><name name-style="western"><surname>Erttmann</surname><given-names>K.D.</given-names></name><name name-style="western"><surname>Luersen</surname><given-names>K.</given-names></name><name name-style="western"><surname>Liebau</surname><given-names>E.</given-names></name><etal>et al.</etal></person-group><year>2012</year><article-title>Characterization of a secreted macrophage migration inhibitory factor homologue of the parasitic nematode <italic toggle="yes">Strongyloides</italic> acting at the parasite&#8211;host cell interface</article-title><source>Microbes Infect.</source><volume>14</volume><fpage>279</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1016/j.micinf.2011.09.006</pub-id><pub-id pub-id-type="pmid">22037391</pub-id></element-citation></ref><ref id="BCJ-2025-3061C102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Cho</surname><given-names>M.K.</given-names></name><name name-style="western"><surname>Park</surname><given-names>H.K.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>K.H.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>S.H.</given-names></name><etal>et al.</etal></person-group><year>2009</year><article-title>Macrophage migration inhibitory factor homologs of anisakis simplex suppress Th2 response in allergic airway inflammation model via CD4&#8314;CD25&#8314;Foxp3&#8314; T cell recruitment</article-title><source>J. Immunol.</source><volume>182</volume><fpage>6907</fpage><lpage>6914</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0803533</pub-id><pub-id pub-id-type="pmid">19454687</pub-id></element-citation></ref><ref id="BCJ-2025-3061C103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fitzsimmons</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Schramm</surname><given-names>G.</given-names></name><name name-style="western"><surname>Jones</surname><given-names>F.M.</given-names></name><name name-style="western"><surname>Chalmers</surname><given-names>I.W.</given-names></name><name name-style="western"><surname>Hoffmann</surname><given-names>K.F.</given-names></name><name name-style="western"><surname>Grevelding</surname><given-names>C.G.</given-names></name><etal>et al.</etal></person-group><year>2005</year><article-title>Molecular characterization of omega-1: a hepatotoxic ribonuclease from <italic toggle="yes">Schistosoma mansoni</italic> eggs</article-title><source>Mol. Biochem. Parasitol.</source><volume>144</volume><fpage>123</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1016/j.molbiopara.2005.08.003</pub-id><pub-id pub-id-type="pmid">16143411</pub-id></element-citation></ref><ref id="BCJ-2025-3061C104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Everts</surname><given-names>B.</given-names></name><name name-style="western"><surname>Perona-Wright</surname><given-names>G.</given-names></name><name name-style="western"><surname>Smits</surname><given-names>H.H.</given-names></name><name name-style="western"><surname>Hokke</surname><given-names>C.H.</given-names></name><name name-style="western"><surname>van der Ham,</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Fitzsimmons</surname><given-names>C.M.</given-names></name><etal>et al.</etal></person-group><year>2009</year><article-title>Omega-1, a glycoprotein secreted by <italic toggle="yes">Schistosoma mansoni</italic> eggs, drives Th2 responses</article-title><source>J. Exp. Med.</source><volume>206</volume><fpage>1673</fpage><lpage>1680</lpage><pub-id pub-id-type="doi">10.1084/jem.20082460</pub-id><pub-id pub-id-type="pmid">19635864</pub-id><pub-id pub-id-type="pmcid">PMC2722183</pub-id></element-citation></ref><ref id="BCJ-2025-3061C105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Steinfelder</surname><given-names>S.</given-names></name><name name-style="western"><surname>Andersen</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Cannons</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>C.G.</given-names></name><name name-style="western"><surname>Joshi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Dwyer</surname><given-names>D.</given-names></name><etal>et al.</etal></person-group><year>2009</year><article-title>The major component in schistosome eggs responsible for conditioning dendritic cells for Th2 polarization is a T2 ribonuclease (omega-1)</article-title><source>J. Exp. Med.</source><volume>206</volume><fpage>1681</fpage><lpage>1690</lpage><pub-id pub-id-type="doi">10.1084/jem.20082462</pub-id><pub-id pub-id-type="pmid">19635859</pub-id><pub-id pub-id-type="pmcid">PMC2722182</pub-id></element-citation></ref><ref id="BCJ-2025-3061C106"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Everts</surname><given-names>B.</given-names></name><name name-style="western"><surname>Hussaarts</surname><given-names>L.</given-names></name><name name-style="western"><surname>Driessen</surname><given-names>N.N.</given-names></name><name name-style="western"><surname>Meevissen</surname><given-names>M.H.J.</given-names></name><name name-style="western"><surname>Schramm</surname><given-names>G.</given-names></name><name name-style="western"><surname>van der Ham,</surname><given-names>A.J.</given-names></name><etal>et al.</etal></person-group><year>2012</year><article-title>Schistosome-derived omega-1 drives Th2 polarization by suppressing protein synthesis following internalization by the mannose receptor</article-title><source>J. Exp. Med.</source><volume>209</volume><fpage>1753</fpage><lpage>1767</lpage><pub-id pub-id-type="doi">10.1084/jem.20111381</pub-id><pub-id pub-id-type="pmid">22966004</pub-id><pub-id pub-id-type="pmcid">PMC3457738</pub-id></element-citation></ref><ref id="BCJ-2025-3061C107"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferguson</surname><given-names>B.J.</given-names></name><name name-style="western"><surname>Newland</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Gibbs</surname><given-names>S.E.</given-names></name><name name-style="western"><surname>Tourlomousis</surname><given-names>P.</given-names></name><name name-style="western"><surname>Fernandes dos Santos</surname><given-names>P.</given-names></name><name name-style="western"><surname>Patel</surname><given-names>M.N.</given-names></name><etal>et al.</etal></person-group><year>2015</year><article-title>The <italic toggle="yes">Schistosoma mansoni</italic> T2 ribonuclease omega-1 modulates inflammasome-dependent IL-1&#946; secretion in macrophages</article-title><source>Int. J. Parasitol.</source><volume>45</volume><fpage>809</fpage><lpage>813</lpage><pub-id pub-id-type="doi">10.1016/j.ijpara.2015.08.005</pub-id><pub-id pub-id-type="pmid">26385440</pub-id></element-citation></ref><ref id="BCJ-2025-3061C108"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patente</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Gasan</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Scheenstra</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ozir-Fazalalikhan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Obieglo</surname><given-names>K.</given-names></name><name name-style="western"><surname>Schetters</surname><given-names>S.</given-names></name><etal>et al.</etal></person-group><year>2024</year><article-title><italic toggle="yes">S. mansoni</italic> -derived omega-1 prevents OVA-specific allergic airway inflammation via hampering of cDC2 migration</article-title><source>Plos Pathog.</source><volume>20</volume><elocation-id>e1012457</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1012457</pub-id><pub-id pub-id-type="pmid">39186814</pub-id><pub-id pub-id-type="pmcid">PMC11379383</pub-id></element-citation></ref><ref id="BCJ-2025-3061C109"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zawistowska-Deniziak</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lambooij</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Kalinowska</surname><given-names>A.</given-names></name><name name-style="western"><surname>Patente</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>&#321;api&#324;ski</surname><given-names>M.</given-names></name><name name-style="western"><surname>van der Zande,</surname><given-names>H.J.P.</given-names></name><etal>et al.</etal></person-group><year>2022</year><article-title><italic toggle="yes">Fasciola hepatica</italic> fatty acid binding protein 1 modulates T cell polarization by promoting dendritic cell thrombospondin-1 secretion without affecting metabolic homeostasis in obese mice</article-title><source>Front. Immunol.</source><volume>13</volume><elocation-id>884663</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2022.884663</pub-id><pub-id pub-id-type="pmid">35720355</pub-id><pub-id pub-id-type="pmcid">PMC9204345</pub-id></element-citation></ref><ref id="BCJ-2025-3061C110"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pineda</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Lumb</surname><given-names>F.</given-names></name><name name-style="western"><surname>Harnett</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Harnett</surname><given-names>W</given-names></name></person-group><year>2014</year><article-title>ES-62, a therapeutic anti-inflammatory agent evolved by the filarial nematode <italic toggle="yes">Acanthocheilonema viteae</italic></article-title><source>Mol. Biochem. Parasitol.</source><volume>194</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.molbiopara.2014.03.003</pub-id><pub-id pub-id-type="pmid">24671112</pub-id></element-citation></ref><ref id="BCJ-2025-3061C111"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goodridge</surname><given-names>H.S.</given-names></name><name name-style="western"><surname>Marshall</surname><given-names>F.A.</given-names></name><name name-style="western"><surname>Else</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Houston</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Egan</surname><given-names>C.</given-names></name><name name-style="western"><surname>Al-Riyami</surname><given-names>L.</given-names></name><etal>et al.</etal></person-group><year>2005</year><article-title>Immunomodulation via novel use of TLR4 by the filarial nematode phosphorylcholine-containing secreted product, ES-62</article-title><source>J. Immunol.</source><volume>174</volume><fpage>284</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.174.1.284</pub-id><pub-id pub-id-type="pmid">15611251</pub-id></element-citation></ref><ref id="BCJ-2025-3061C112"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haeberlein</surname><given-names>S.</given-names></name><name name-style="western"><surname>Obieglo</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ozir-Fazalalikhan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Chay&#233;</surname><given-names>M.A.M.</given-names></name><name name-style="western"><surname>Veninga</surname><given-names>H.</given-names></name><name name-style="western"><surname>van der Vlugt,</surname><given-names>L.E.P.M.</given-names></name><etal>et al.</etal></person-group><year>2017</year><article-title>Schistosome egg antigens, including the glycoprotein IPSE/alpha-1, trigger the development of regulatory B cells</article-title><source>Plos Pathog.</source><volume>13</volume><elocation-id>e1006539</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1006539</pub-id><pub-id pub-id-type="pmid">28753651</pub-id><pub-id pub-id-type="pmcid">PMC5550006</pub-id></element-citation></ref><ref id="BCJ-2025-3061C113"><label>113</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chay&#233;</surname><given-names>M.A.M.</given-names></name><name name-style="western"><surname>Gasan</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Ozir-Fazalalikhan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Scheenstra</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Zawistowska-Deniziak</surname><given-names>A.</given-names></name><name name-style="western"><surname>van Hengel,</surname><given-names>O.R.J.</given-names></name><etal>et al.</etal></person-group><year>2023</year><article-title><italic toggle="yes">Schistosoma mansoni</italic> egg-derived thioredoxin and Sm14 drive the development of IL-10 producing regulatory B cells</article-title><source>Plos Negl. Trop. Dis.</source><volume>17</volume><elocation-id>e0011344</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0011344</pub-id><pub-id pub-id-type="pmid">37363916</pub-id><pub-id pub-id-type="pmcid">PMC10328244</pub-id></element-citation></ref><ref id="BCJ-2025-3061C114"><label>114</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hams</surname><given-names>E.</given-names></name><name name-style="western"><surname>Bermingham</surname><given-names>R.</given-names></name><name name-style="western"><surname>Wurlod</surname><given-names>F.A.</given-names></name><name name-style="western"><surname>Hogan</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>O&#8217;Shea</surname><given-names>D.</given-names></name><name name-style="western"><surname>Preston</surname><given-names>R.J.</given-names></name><etal>et al.</etal></person-group><year>2016</year><article-title>The helminth T2 RNase &#969;1 promotes metabolic homeostasis in an IL-33- and group 2 innate lymphoid cell-dependent mechanism</article-title><source>FASEB J.</source><volume>30</volume><fpage>824</fpage><lpage>835</lpage><pub-id pub-id-type="doi">10.1096/fj.15-277822</pub-id><pub-id pub-id-type="pmid">26490658</pub-id><pub-id pub-id-type="pmcid">PMC4973506</pub-id></element-citation></ref><ref id="BCJ-2025-3061C115"><label>115</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van der Zande,</surname><given-names>H.J.P.</given-names></name><name name-style="western"><surname>Gonzalez</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>de Ruiter,</surname><given-names>K.</given-names></name><name name-style="western"><surname>Wilbers</surname><given-names>R.H.P.</given-names></name><name name-style="western"><surname>Garc&#237;a-Tard&#243;n</surname><given-names>N.</given-names></name><name name-style="western"><surname>van Huizen,</surname><given-names>M.</given-names></name><etal>et al.</etal></person-group><year>2021</year><article-title>The helminth glycoprotein omega-1 improves metabolic homeostasis in obese mice through type 2 immunity-independent inhibition of food intake</article-title><source>FASEB J.</source><volume>35</volume><elocation-id>e21331</elocation-id><pub-id pub-id-type="doi">10.1096/fj.202001973R</pub-id><pub-id pub-id-type="pmid">33476078</pub-id><pub-id pub-id-type="pmcid">PMC7898285</pub-id></element-citation></ref><ref id="BCJ-2025-3061C116"><label>116</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schnoeller</surname><given-names>C.</given-names></name><name name-style="western"><surname>Rausch</surname><given-names>S.</given-names></name><name name-style="western"><surname>Pillai</surname><given-names>S.</given-names></name><name name-style="western"><surname>Avagyan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wittig</surname><given-names>B.M.</given-names></name><name name-style="western"><surname>Loddenkemper</surname><given-names>C.</given-names></name><etal>et al.</etal></person-group><year>2008</year><article-title>A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-producing macrophages</article-title><source>J. Immunol.</source><volume>180</volume><fpage>4265</fpage><lpage>4272</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.180.6.4265</pub-id><pub-id pub-id-type="pmid">18322239</pub-id></element-citation></ref><ref id="BCJ-2025-3061C117"><label>117</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ji</surname><given-names>P.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name><etal>et al.</etal></person-group><year>2015</year><article-title>AcCystatin, an immunoregulatory molecule from <italic toggle="yes">Angiostrongylus cantonensis</italic>, ameliorates the asthmatic response in an aluminium hydroxide/ovalbumin-induced rat model of asthma</article-title><source>Parasitol. Res.</source><volume>114</volume><fpage>613</fpage><lpage>624</lpage><pub-id pub-id-type="doi">10.1007/s00436-014-4223-z</pub-id><pub-id pub-id-type="pmid">25399816</pub-id></element-citation></ref><ref id="BCJ-2025-3061C118"><label>118</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coronado</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zakzuk</surname><given-names>J.</given-names></name><name name-style="western"><surname>Regino</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ahumada</surname><given-names>V.</given-names></name><name name-style="western"><surname>Benedetti</surname><given-names>I.</given-names></name><name name-style="western"><surname>Angelina</surname><given-names>A.</given-names></name><etal>et al.</etal></person-group><year>2019</year><article-title><italic toggle="yes">Ascaris lumbricoides</italic> cystatin prevents development of allergic airway inflammation in a mouse model</article-title><source>Front. Immunol.</source><volume>10</volume><elocation-id>2280</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2019.02280</pub-id><pub-id pub-id-type="pmid">31611876</pub-id><pub-id pub-id-type="pmcid">PMC6777510</pub-id></element-citation></ref><ref id="BCJ-2025-3061C119"><label>119</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Acevedo</surname><given-names>N.</given-names></name><name name-style="western"><surname>Lozano</surname><given-names>A.</given-names></name><name name-style="western"><surname>Zakzuk</surname><given-names>J.</given-names></name><name name-style="western"><surname>Llin&#225;s-Caballero</surname><given-names>K.</given-names></name><name name-style="western"><surname>Brodin</surname><given-names>D.</given-names></name><name name-style="western"><surname>Nejsum</surname><given-names>P.</given-names></name><etal>et al.</etal></person-group><year>2024</year><article-title>Cystatin from the helminth <italic toggle="yes">Ascaris lumbricoides</italic> upregulates mevalonate and cholesterol biosynthesis pathways and immunomodulatory genes in human monocyte-derived dendritic cells</article-title><source>Front. Immunol.</source><volume>15</volume><elocation-id>1328401</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2024.1328401</pub-id><pub-id pub-id-type="pmid">38481989</pub-id><pub-id pub-id-type="pmcid">PMC10936004</pub-id></element-citation></ref><ref id="BCJ-2025-3061C120"><label>120</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quinteros</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>von Krusenstiern,</surname><given-names>E.</given-names></name><name name-style="western"><surname>Snyder</surname><given-names>N.W.</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>A.</given-names></name><name name-style="western"><surname>O&#8217;Brien</surname><given-names>B.</given-names></name><name name-style="western"><surname>Donnelly</surname><given-names>S</given-names></name></person-group><year>2023</year><article-title>The helminth derived peptide FhHDM-1 redirects macrophage metabolism towards glutaminolysis to regulate the pro-inflammatory response</article-title><source>Front. Immunol.</source><volume>14</volume><elocation-id>1018076</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2023.1018076</pub-id><pub-id pub-id-type="pmid">36761766</pub-id><pub-id pub-id-type="pmcid">PMC9905698</pub-id></element-citation></ref><ref id="BCJ-2025-3061C121"><label>121</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bohnacker</surname><given-names>S.</given-names></name><name name-style="western"><surname>Henkel</surname><given-names>F.D.R.</given-names></name><name name-style="western"><surname>Hartung</surname><given-names>F.</given-names></name><name name-style="western"><surname>Geerlof</surname><given-names>A.</given-names></name><name name-style="western"><surname>Riemer</surname><given-names>S.</given-names></name><name name-style="western"><surname>Prodjinotho</surname><given-names>U.F.</given-names></name><etal>et al.</etal></person-group><year>2024</year><article-title>A helminth enzyme subverts macrophage-mediated immunity by epigenetic targeting of prostaglandin synthesis</article-title><source>Sci. Immunol.</source><volume>9</volume><elocation-id>eadl1467</elocation-id><pub-id pub-id-type="doi">10.1126/sciimmunol.adl1467</pub-id><pub-id pub-id-type="pmid">39642243</pub-id></element-citation></ref><ref id="BCJ-2025-3061C122"><label>122</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mart&#237;nez-Reyes</surname><given-names>I.</given-names></name><name name-style="western"><surname>Chandel</surname><given-names>N.S</given-names></name></person-group><year>2020</year><article-title>Mitochondrial TCA cycle metabolites control physiology and disease</article-title><source>Nat. Commun.</source><volume>11</volume><fpage>102</fpage><pub-id pub-id-type="doi">10.1038/s41467-019-13668-3</pub-id><pub-id pub-id-type="pmid">31900386</pub-id><pub-id pub-id-type="pmcid">PMC6941980</pub-id></element-citation></ref><ref id="BCJ-2025-3061C123"><label>123</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Orr</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>H.T.C.</given-names></name><name name-style="western"><surname>James</surname><given-names>S.</given-names></name><name name-style="western"><surname>Penfold</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J.</given-names></name><etal>et al.</etal></person-group><year>2023</year><article-title>Reducing affinity as a strategy to boost immunomodulatory antibody agonism</article-title><source>Nature</source><volume>614</volume><fpage>539</fpage><lpage>547</lpage><pub-id pub-id-type="doi">10.1038/s41586-022-05673-2</pub-id><pub-id pub-id-type="pmid">36725933</pub-id></element-citation></ref><ref id="BCJ-2025-3061C124"><label>124</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>H.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kuan</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>B.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><etal>et al.</etal></person-group><year>2023</year><article-title>Pathogen protein modularity enables elaborate mimicry of a host phosphatase</article-title><source>Cell</source><volume>186</volume><fpage>3196</fpage><lpage>3207</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2023.05.049</pub-id><pub-id pub-id-type="pmid">37369204</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>